Adult Medicine PRN

 Promotions

• Joshua Gaborcik: Lead Internal Medicine Pharmacist, Ohio State University Wexner Medical Center.
• Bao Anh Tran: Interim Director of Academic Success, USF Taneja College of Pharmacy.

 Publications

• Ball NS, Bredhold B, Ward A, Demkowicz R, Martello JL. Assessing 30-day recurrence for patients testing indeterminate for Clostridioides difficile based on treatment status. Anaerobe. 2025;96:103012. https://doi.org/10.1016/j.anaerobe.2025.103012
• Ball NS, Kinney EM, McMahan E, Wietholter JP. Assessing inpatient formulary-driven inhaler use in presumed group B chronic obstructive pulmonary disease. J Am Pharm Assoc (2003). 2025;65(6):102916. https://doi.org/10.1016/j.japh.2025.102916
• Murchison A, Ball N, Rockhold M, Bredhold B. Treatment failure in patients with obesity with venous thromboembolism receiving truncated vs. recommended lead-in times with apixaban at an academic medical center. J Thromb Thrombolysis. 2025 Sep 15. [Epub ahead of print]. https://doi.org/10.1007/s11239-025-03181-4
• Alpert JM, Kovach JD, Casacchia NJ, et al. Hospitalization experiences among nursing home residents with dementia. J Am Med Dir Assoc. 2026;27(2):106022. https://doi.org/10.1016/j.jamda.2025.106022
• Gasoyan H, Alavi MH, Zajichek A, Casacchia NJ, et al. Macrovascular and microvascular outcomes of metabolic surgery versus GLP-1 receptor agonists in patients with diabetes and obesity. Nat Med. 2025;31(10):3341-3349. https://doi.org/10.1038/s41591-025-03893-3
• Gasoyan H, Butsch WS, Casacchia NJ, et al. Reasons for discontinuation of obesity pharmacotherapy with semaglutide or tirzepatide in clinical practice. Obesity (Silver Spring). 2025;33(12):2296-2303. https://doi.org/10.1002/oby.70058
• Lababidi H, Theocharides VA, Gonzalez J. Comparison of ideal vs. actual body weight dosing of intravenous immunoglobulins for immune thrombocytopenia: a retrospective analysis. Adv Hematol. 2025 Dec 1. [Epub ahead of print]. https://doi.org/10.1155/ah/8770122
• Khan RW, Gipson G. Disorders of potassium and magnesium homeostasis. In: Haines ST, Nolin TD, Ellingrod VL, et al, eds. Pharmacotherapy: A Pathophysiologic Approach. 13th ed. McGraw Hill; 2026.
• Khan RW, Zacholski EH. Active learning strategies. In: Koehler JM, Borchert JS, Slain D, et al, eds. Schwinghammer’s Pharmacotherapy Casebook: A Patient-Focused Approach. 13th ed. McGraw Hill; 2026.
• Laswell E, Peterson K, Duan H, Grinalds M. Rapid administration of antiseizure medications: review of safety, effectiveness, and implications for pharmacy practice. Am J Health Syst Pharm. 2026;83(4):131-150. https://doi.org/10.1093/ajhp/zxaf214
• Poole SS, Bethea A, Brewington E, et al. Predictors of discrepancies between Cockcroft-Gault and Chronic Kidney Disease-EPI creatinine-cystatin in hospitalized patients. Ann Pharmacother. 2025 Aug 27. [Epub ahead of print]. https://doi.org/10.1177/10600280251356492
• Richter L, Taylor S, Soric MM. Declining pharmacy student enrollment, its impact on health-system pharmacy, and a call to action. Am J Health Syst Pharm. 2025;82(18):1031-1034. https://doi.org/10.1093/ajhp/zxaf062
• Vergara M, Soric MM, King O, et al. Prescribing patterns of gabapentinoids in patients with chronic obstructive pulmonary disorder. COPD. 2026;23(1):2596683. https://doi.org/10.1080/15412555.2025.2596683
• Barchet AC, Fleming JN, Rydz A, Steuber TD, Thayer BG. Real-world evaluation of a pneumonia PCR panel: appropriateness, outcomes, and antimicrobial stewardship implications. Hosp Pharm. 2025 Dec 1. [Epub ahead of print]. https://doi.org/10.1177/00185787251393063
• Krsak M, Klimpl D, Mueller SW, Morrisette T, Grimshaw AA, Chastain D, Steuber TD, et al. Oritavancin for treatment of osteomyelitis: a systematic review and meta-analysis of observational studies. Pharmacotherapy. 2025;45(11):754-763. https://doi.org/10.1002/phar.70072
• Salvatore D, Moore J, Steuber TD. Long-acting lipoglycopeptides compared to standard-of-care for the treatment of complicated gram-positive infections: a systematic review and meta-analysis. Int J Antimicrob Agents. 2025;66(5):107581. https://doi.org/10.1016/j.ijantimicag.2025.107581
• Stropes A, Lautenschlager C, Smith AJ, Steuber TD, Sperry M. Linezolid versus clindamycin for toxin inhibition in severe skin and soft tissue infections: a systematic review and meta-analysis. Infection. 2026 Jan 8. [Epub ahead of print]. https://doi.org/10.1007/s15010-025-02722-6
• Loeb A, Szwak JA, Sperry JD. Resident perspectives on conducting a multicenter research experience. Am J Health Syst Pharm. 2026;83(suppl 1):S13-S19. https://doi.org/10.1093/ajhp/zxaf253
• Tran BAC, Wantuch GA, Mangasar M, Miranda AC. Battle of the (chat)bots: comparative evaluation of April 2025 AI model accuracy on pharmacotherapeutic cases. Am J Pharm Educ. 2026;90(1):101922. https://doi.org/10.1016/j.ajpe.2025.101922
• Terpening CM, Wietholter JP. Dihydroergotamine intranasal powder for acute migraine treatment. Ann Pharmacother. 2025 Dec 4. [Epub ahead of print]. https://doi.org/10.1177/10600280251388440

Presentations

• Nicole Asal: Practical pearls and regulatory realities in pharmacotherapy for older adults. Presented at: Heber W. Youngken, Jr. Pharmacy Clinic; November 2025; virtual.
• Emily Hanners Dunn: Targeting DNA repair: the use of PARP inhibitors in prostate cancer. Presented at: Illinois Council of Health-System Pharmacists Annual Meeting; September 2025; Oakbrook Terrace, IL.
• Emily Kostelic: Practice-enhancing interventions and the ambulatory care medication-use process from 2024: gems from selected AJHP articles. Presented at: American Society of Health-System Pharmacists Midyear Clinical Meeting; December 2025; Las Vegas, NV.

New ACCP Fellows

• Luigi Brunetti
• Dustin Carneal
• Megan Herink
• Rachel W. Khan
• Philip K. King
• Nicole L. Metzger
• Branden D. Nemecek
• Sara K. Richter
• Ashley E. Woodruff

Other Notable Achievements

• Mary Teresa Ambrosini: Reviewer for Journal of the American Heart Association and Journal of Pharmacy Technology.
• Savannah Poole: Received BCPS certification.
• Leslie Wooten: BPS Pharmacotherapy Specialty Council 2026-2028.

Ambulatory Care PRN

Promotions

• Kelly A. Cochran: Adjunct Clinical Professor, UMKC School of Pharmacy.
• Marissa Salvo: Clinical Professor of Pharmacy Practice, UConn School of Pharmacy.
• Zach Krauss: Clinical Manager, Ambulatory Care and Medication Access Services, UVA Health.

Awards

• Kate Cozart: Student Advocate Award, Tennessee Pharmacists Association.
• Alexis Horace:
  • Agent of Change Award 2025, University of Louisiana Systems.
  • Clinical Sciences Best Manuscript of the Year 2025, University of Louisiana at Monroe College of Pharmacy.
• Melissa Lipari: 2025 Excellence in Teaching Award, Wayne State University EACPHS.
• Michelle Patterson: The Outpatient Teaching Group of the Year Award, Penn Medicine Lancaster General Health Family Medicine Residency Program.
• Marissa Salvo: Bowl of Hygeia, Connecticut Pharmacists Association.
• Saley Traore-Uwalaka: Correct Rx Pharmacy President’s Award, Correct Rx Pharmacy Services, Inc.

Publications

• Barry AR, Helisaz H, Safari A, Loewen PS. Effect of P2Y₁₂ inhibitors on major adverse cardiovascular events after coronary artery bypass graft surgery: a population-based cohort study. Pharmacotherapy. 2025;45(9):557-565. https://doi.org/10.1002/phar.70047
• Barry AR, Mattarollo E, Tsuyuki RT. Should all pharmacies have an automated external defibrillator? Can Pharm J (Ott). 2025;158(1 suppl):2S-5S. https://doi.org/10.1177/17151635251382594
• Barry AR, Tsuyuki RT. The landscape of automated external defibrillators in pharmacies: a preliminary survey. Can Pharm J (Ott). 2025;158(1 suppl):9S-11S. https://doi.org/10.1177/17151635251382588
• Mattarollo E, Tsuyuki RT, Barry AR. Pharmacies and automated external defibrillators: a literature review. Can Pharm J (Ott). 2025;158(1 suppl):6S-8S. https://doi.org/10.1177/17151635251382587
• Tsuyuki RT, Barry AR. Pharmacists’ experience with automated external defibrillators. Can Pharm J (Ott). 2025;158(1 suppl):12S-14S. https://doi.org/10.1177/17151635251382591
• Xu S, Barry AR, Basiratmanesh S, et al. Patients’ perceptions of pharmacist prescribing for minor ailments and contraception in British Columbia, Canada. J Am Coll Clin Pharm. 2026;9(1):e70168. https://doi.org/10.1002/jac5.70168
• Billups SJ, Daffron A, Harty C, Lowe RN, Lobo I. Centralized outreach with embedded pharmacist e-consultation to reduce therapeutic inertia and improve blood pressure control. Am J Health Syst Pharm. 2025;82(22):1249-1255. https://doi.org/10.1093/ajhp/zxaf096
• Billups SJ, Fraumeni BR, Bauguess HD, et al. Improving access to rheumatology care: evaluation of a rheumatology electronic consultation program. Arthritis Care Res. 2025 Nov 28. [Epub ahead of print]. https://doi.org/10.1002/acr.70003
• Claus LW, Auten M, Saseen JJ, Billups SJ. Guideline adherence of xanthine oxidase inhibitor utilization to treat gout in primary care. J Manag Care Spec Pharm. 2025;31(9):922-927. https://doi.org/10.18553/jmcp.2025.31.9.922
• Keime N, Titus O, Ziogaite M, Hugh J, Schilling L, Dellavalle R, Billups SJ. Primary care physicians prescribe fewer expensive combination medications than dermatologists for acne: a retrospective review. J Manag Care Spec Pharm. 2025;31(12):1237-1243. https://doi.org/10.18553/jmcp.2025.31.12.1237
• Lobo I, Koon K, Potthast K, Ozmina K, Billups SJ. A multi-intervention approach to blood pressure control: a description of how a large university-based primary care clinic tackled hypertension. Pop Health Mgmt. 2026;29(1):18-26. https://doi.org/10.1177/19427891251393941
• Worledge E, Billups SJ, Titus OJ, Saseen JJ. Achievement of low-density lipoprotein cholesterol thresholds in very high-risk atherosclerotic cardiovascular disease. J Clin Lipidol. 2025;19(4):860-868. https://doi.org/10.1016/j.jacl.2025.04.186
• Elmes-Patel A, Jarrett JB, Jimenez AD, Mayer SM, Messmer SM. Expanding access to opioid use disorder treatment: low-threshold buprenorphine dispensing via an interprofessional mobile medical unit in Chicago. J Am Coll Clin Pharm. 2026;9(2):e70170. https://doi.org/10.1002/jac5.70170
• Martinford T, Watson DP, Messmer SM, Rashid LM, Staton M, Dennis ML, Grella CE, Elmes-Patel A. “Convenience, quickness, and compassion”: experiences of people involved in the criminal‐legal system accessing medications for opioid use disorder services from a mobile unit in Chicago. Health Expect. 2026;29(1):e70552. https://doi.org/10.1111/hex.70552
• Shah KK, Messmer S, Elmes-Patel A, Touchette DR. Economic analysis of a low-threshold mobile medical unit dispensing buprenorphine for opioid use disorder. J Subst Use Addict Treat. 2026;184:209900. https://doi.org/10.1016/j.josat.2026.209900
• Horace AE, Below J, Brown A, Hill S. Equipping the front lines: building a harm reduction program for Louisiana first responders. J Am Pharm Assoc. 2026;66(1):102945. https://doi.org/10.1016/j.japh.2025.102945
• Hill S 2nd, Hurst T, Hamilton M, Brian M, Below J, Brown A, Garza O, Horace A. Assessing knowledge and beliefs in harm reduction strategies among student pharmacists: a pilot study. Curr Pharm Teach Learn. 2025;17(8):102364. https://doi.org/10.1016/j.cptl.2025.102364
• Nguyễn J, Edwards D, Krauss ZJ, Abdalla M. Best practices for the use of person-centered and inclusive language in clinical pharmacy practice, education, and research: an opinion paper and call to action from the American College of Clinical Pharmacy Health Equity Practice Research Network. J Am Coll Clin Pharm. 2025;8(9):931-950. https://doi.org/10.1002/jac5.70093
• Lipari M, Garwood CL, Berlie HN, Leonard C. Clinician perceptions of therapeutic inertia in type 2 diabetes mellitus: a qualitative study. J Am Coll Clin Pharm. 2026;9(2):ee70146. https://doi.org/10.1002/jac5.70146
• Ammar A, Sorochak N, Paxton R, Lipari M, Giuliano C. Association between the use of long-acting insulin and hypoglycemia in critically ill patients with diabetes. J Intensive Care Med. 2025 Sep 1. [Epub ahead of print]. https://doi.org/10.1177/08850666251371709
• Martirosov AL, Abdalla M, Fleischman M, Foster B, Gonzales J, Lipari M, et al. Navigating the alphabet soup of interstitial lung diseases (ILD): the role of pharmacists. J Am Coll Clin Pharm. 2025;8(10):1027-1045. https://doi.org/10.1002/jac5.7008
• Williamson B, Thompson J, Olson JL, Hays E. Implementation of a novel ambulatory care pharmacist training program to facilitate redeployment of community pharmacists. Am J Health Syst Pharm. 2025 Nov 8. [Epub ahead of print]. https://doi.org/10.1093/ajhp/zxaf284
• Jeschonnek A, Patterson ML. Pharmacologic considerations for MASLD and MASH. J Lancaster Gen Hosp. 2025;20(3):79-83. https://www.jlgh.org/JLGH/media/Volume-20-Issue-3/20_3-jeschonnek-mash.pdf
• Schumacher C. Cardiovascular-kidney-metabolic (CKM) syndrome. In: Sanoski CA, Witt DM, eds. Pharmacotherapy Self-Assessment Program, 2026 Book 1. Endocrinology and Nephrology. American College of Clinical Pharmacy; 2026:1-18.
• Singh-Franco D, Krichbaum M, Paprota J, et al. Breaking bias: an interprofessional approach to reducing stigma towards patients with substance use disorders in health professions education. J Am Coll Clin Pharm. 2025;8(12):1252-1265. https://doi.org/10.1002/jac5.70140
• Santibañez M, Lounsbury N, Morena M, Singh-Franco D. Thrombosis secondary to intravenous dicyclomine administration: a case report and literature review. J Pharm Pract. 2026;39:50-56. https://doi.org/10.1177/08971900251326808
• Lingow S, Carris N, Clements J, Courtney L, Lennon A, Sherrill CH, Van Dril E. The pharmacist’s role in the use of incretin-based therapies for weight management: an opinion of the Endocrine and Metabolism Practice and Research Network of the American College of Clinical Pharmacy. J Am Coll Clin Pharm. 2025;8(10):1078-1093. https://doi.org/10.1002/jac5.70111
• Pham J, Donohoe KL, Wijesinghe DS, Van Tassell B, Wheeler SE, et al. Comparison of peer, near-peer, and AI-assisted methods to faculty grading of SOAP notes. Am J Pharm Educ. 2025;89(11):101877. https://doi.org/10.1016/j.ajpe.2025.101877

Presentations

• Sarah J. Billups:
  • Applying a clinical lens to medication adherence quality measures—do they measure up? Presented at: American Society of Health-System Pharmacists Midyear Clinical Meeting; December 7, 2025; Las Vegas, NV.
  • Health outcomes: designing and implementing collaborations between clinical pharmacists and physicians. Presented at: 2025 ACCP Annual Meeting; October 18, 2025; Minneapolis, MN.
  • Getting payment for pharmacist services through a medical billing partnership with a physician practice. Presented at: Align Conference; September 25, 2025; Minneapolis, MN.
  • Making patients healthier one millimeter of mercury at a time. Presented at: Tennessee Heart Health Learning Collaborative Webinar; July 29, 2025; virtual.
• Kelly A. Cochran:
  • How to create and facilitate a successful multidisciplinary clinical rural immersion program. Presented at: Society of Teachers of Family Medicine Annual Spring Conference; May 2025; Salt Lake City, UT.
  • Rural rotations reimagined: interprofessional collaboration and community engagement. Presented at: National Rural Health Association Annual Conference; May 2025; Atlanta, GA.
• Kate Cozart:
  • Confidence in care: supporting Gen Z learners to overcome impostor phenomenon in the patient care setting. Presented at: Veterans Affairs National Preceptors/RPDs virtual conference; September 2025; virtual.
  • Compassion: cultivating the worldwide wonder drug. Presented at: Phi Lambda Sigma Leadership Summit; September 2025; virtual.
  • Navigating the storms of self-doubt without burning out. Presented at: Belmont University College of Pharmacy SSHP-ASHP General Body Meeting; October 2025; Nashville, TN.
  • Federal burnout: why it happens and what we can do. Presented at: ASHP Midyear Federal Forum; December 2025; Las Vegas, NV.
  • Paving the way for better communities: treating alcohol use disorder. Presented at: Tennessee Association of Recovery Court Professionals; December 2025; Murfreesboro, TN.
• Abigail Elmes-Patel:
  • Debating the future of opioid overdose reversal: nalmefene or naloxone? Presented at: American Society of Health-System Pharmacists Midyear Meeting; December 2025; Las Vegas, NV.
  • LOI: letter of intent or lack of interest—a guide for drafting letters of intent for postgraduate opportunities. Presented at: American Society of Health-System Pharmacists Midyear Meeting; December 2025; Las Vegas, NV.
  • Mapping need, making change: population health in practice. Presented at: American Society of Health-System Pharmacists Midyear Meeting; December 2025; Las Vegas, NV.
• Zach Krauss: The role of biomarkers in pulmonary diseases. Presented at: 2025 ACCP Annual Meeting; October 2025; Minneapolis, MN.
• Jeff Olson:
  • Stacking the deck: population health workflows & metrics. Presented at: ASHP Midyear Clinical Meeting; December 2025; Las Vegas, NV.
  • Betting on primary care transformation: pharmacists leading the way in value-based care. Presented at: ASHP Midyear Clinical Meeting; December 2025; Las Vegas, NV.
• Michelle Patterson: Implementing a layered-learning model in your practice. Presented at: iForumRx; September 6, 2025; virtual.
• Christie Schumacher:
  • Describing current practices and barriers to pharmacist-led outpatient glucagon use in people with diabetes. Presented at: American Diabetes Association 85th Scientific Sessions Poster Session (2056-LB); June 2025; Chicago, IL.
  • Laying the foundation: practical guidance for starting and developing ambulatory care pharmacy services. Presented at: Illinois Council of Health-System Pharmacists Annual Meeting; September 2025; Oakbrook Terrace, IL.
  • The next step in medication reconciliation: integrating comprehensive medication management strategies at care transitions: creating a role for comprehensive medication management in transitions of care. Presented at: 2025 ACCP Annual Meeting; October 2025; Minneapolis, MN.
  • Syncing data and care: using continuous glucose monitoring to improve cardiometabolic kidney care. Presented at: Carle Health Regional Seminar on Diabetes Management; October 2025; Urbana, IL.
  • Beyond glycemic management: evolving therapies for type 2 diabetes and cardiometabolic kidney care. Presented at: Association of Diabetes Care and Education Specialists Michigan Coordinating Body Annual Meeting; October 2025; Lansing, MI.
• Salematou Traore-Uwalaka:
  • Aging behind bars: optimizing medication management for geriatric patients. Presented at: National Conference on Correctional Health Care; November, 4, 2025; Baltimore, MD.
  • Aging, adverse events, and access: the triple threat pharmacy can fix in corrections. Presented at: American Society of Consultant Pharmacists; September 1, 2025; virtual.
• Liz Van Dril:
  • Laying the foundation: practical guidance for starting and developing ambulatory care pharmacy services. Presented at: Illinois Council of Health-System Pharmacists Annual Meeting; September 2025; Oakbrook Terrace, IL.
  • Diabetes management. Presented at: 2026 Commissioned Training on Ambulatory Care Management for Cardiovascular Diseases for Pharmacists Programme; January 2026; virtual (Hong Kong).
  • Dapagliflozin-induced acute pancreatitis in heart failure reduced ejection fraction: a case report and review of the literature. Abstract 665. Poster presented at: 2025 ACCP Annual Meeting; October 2025; Minneapolis, MN.
  • Urate-lowering therapy selection in an HLA-B*5801 positive patient with a history of cardiovascular disease and allopurinol-treated gout: a case report. Abstract 1066. Poster presented at: 2025 ACCP Annual Meeting; October 2025; Minneapolis, MN.
  • TEAM CGM: team support to improve glycemic control using CGM in diverse populations: a pilot study. Abstract 565755. Presented at: American Public Health Association 2025 Annual Meeting & Expo Poster Session; November 2025; Washington, DC.
• Sarah E. Wheeler:
  • Top ten things every clinician should know about MASLD/MASH. Presented at: iForumRx; December 2025; virtual.
  • Therapeutic debates: innovations in diabetes care: should we double down on dual incretins. Presented at: American Society of Health-System Pharmacists Midyear Clinical Meeting; December 2025; Las Vegas, NV.

New ACCP Fellows

• Sarah J. Billups
• Melissa Lipari

Other Notable Achievements

• Alexis E. Horace: Spearheaded, co-led, and is participating in a state education initiative to provide HIV PrEP and PEP for Pharmacists Education, particularly in implantation of services.
• Jeff Olson: Fellow of the American Society of Health-System Pharmacists (FASHP).
• Michelle Patterson: Earned Certified Diabetes Care and Education Specialist (CDCES) credential.
• Christie Schumacher: Selected as a member of the American Diabetes Association Professional Practice Committee, responsible for writing and updating the ADA Standards of Care.
• Saley Traore-Uwalaka: Earned Certified Correctional Health Professional (CCHP) credential.
• Liz Van Dril: Selected as Faculty Panel Chair for the 2026 Endocrinology and Nephrology Pharmacotherapy Self-Assessment Program.

Cardiology PRN

Awards

• Alejandro Perez: ACCP Cardiology PRN 2025 Annual Meeting Resident Travel Award.
• James Tisdale: Stephanie Feldman Aleong National Patient Safety Award, awarded by the College of Pharmacy, Nova Southeastern University and the Drug Safety Institute.

Publications

• Mann L, Whitson BA, McLaughlin E, Andino L, Rozycki A. Safety of parenteral anticoagulation as a bridge to warfarin in patients undergoing mechanical aortic valve replacement. JTCVS Open. 2025;28:131-137. https://doi.org/10.1016/j.xjon.2025.09.020
• Chen C, Jedeon Z, Jaiswal A, Baran DA, Etts K, Baker WL. Utilizing machine learning to identify predictors of corticosteroid discontinuation 1-year after adult heart transplant. Pharmacotherapy. 2026;46(1):e70073. https://doi.org/10.1002/phar.70073
• Fonarow GC, Ahmad FS, Ahmad T, Albert NM, Alexander KM, Baker WL, et al. HF STATS 2025: heart failure epidemiology and outcomes statistics. An updated 2025 report from the Heart Failure Society of America. J Card Fail. 2026;32(2):439-498. https://doi.org/10.1016/j.cardfail.2025.07.007
• Coons JC, Kliner J, Mathier MA, Keebler ME. Medication optimization clinic: answering a call to action. JACC Heart Fail. 2025;13(10):102561. https://doi.org/10.1016/j.jchf.2025.102561
• Mujtaba M, Klimatcheva M, Tsang A, La A, Miklus V, Becker J, Herrman B, Cremeans A, Benedict NJ, Iasella CJ, Smith RE, Coons JC. Outcomes associated with time in therapeutic range for patients receiving intravenous unfractionated heparin. Clin Appl Thromb Hemost. 2025;31:10760296251371003. https://doi.org/10.1177/10760296251371003
• Sahay S, Hernandez NV, Al Aaraj Y, Coons JC, et al. Pericardial effusions and activin signaling inhibitors: a multicentre, real-world experience. Eur Respir J. 2025;66(4):2501040. https://doi.org/10.1183/13993003.01040-2025
• DiDomenico RJ. Engaging in the lost art of reading: the need to connect and evolve with our learners. J Am Coll Clin Pharm. 2025;8(6):420-421. https://doi.org/10.1002/jac5.70044
• DiDomenico RJ, Smith SE, Chan A, Dougherty Z, Griebe K, et al. American College of Clinical Pharmacy white paper: a roadmap for studying the impact of pharmacist board certification on patient outcomes: feasibility, applicability, and methodological considerations. J Am Coll Clin Pharm. 2026;9:e70165. [Epub ahead of print]. https://doi.org/10.1002/jac5.70165
• Anderson KM, Schroeder SE, DiDomenico RJ, et al. Cardiac cachexia: a scientific statement from the American Association of Heart Failure Nurses. Heart Lung. 2025 Nov 21. [Epub ahead of print]. https://doi.org/10.1016/j.hrtlng.2025.11.009
• Di Palo KE, Tiwari SC, DiDomenico RJ. It takes a village: integrating the interdisciplinary heart failure team to optimize guideline-directed medical therapy. J Card Fail. 2026;32(1):29-31. https://doi.org/10.1016/j.cardfail.2025.11.486
• Kim S, Shah K, DiDomenico R, Winn A. ATTR-CM in the U.S.: patterns of healthcare use and medical costs. Circulation. 2025;152(suppl 3):Abstract 4369443. https://doi.org/10.1161/circ.152.suppl_3.4369443
• Ganter M, Bowyer M, Relic E, Sickley R, Warner M, Baker WL, Hollis I. Impact of selective serotonin reuptake inhibitors on bleeding rates in HeartMate 3 left ventricular assist device patients not taking aspirin. Artif Organs. 2025 Dec 15. [Epub ahead of print]. https://doi.org/10.1111/aor.70078
• Carr J, Sikora A, Meyer SA, et al. Individualized de-resuscitation and diuresis strategies in hospitalized patients: a narrative review. Am J Health Syst Pharm. 2025;83(5):e171-e182. https://doi.org/10.1093/ajhp/zxaf217
• Parker R, Coons JC. Arrhythmias. In: Chisholm-Burns M, Kolesar JM, Malone PM, et al, eds. Pharmacotherapy Principles and Practice. 7th ed. McGraw Hill; 2025.
• Perez AD, Simpson RJ, Kome AM, Tungate Lopez S. Emerging therapies targeting lipoprotein(a): pharmacological advances and future directions. J Pharmacol Exp Ther. 2025;392(12):103695. https://doi.org/10.1016/j.jpet.2025.103695
• Murchison A, Ball N, Rockhold MR, Bredhold B. Treatment failure in patients with obesity with venous thromboembolism receiving truncated vs. recommended lead-in times with apixaban at an academic medical center. J Thromb Thrombolysis. 2025 Sep 15. [Epub ahead of print]. https://doi.org/10.1007/s11239-025-03181-4
• Yzaguirre SA, Rockhold MR, Szymanski TW, Kunkel L, Vaughan M, Berzingi S, Lacoste JL. Evaluation of the use of primary prevention aspirin in patients with atrial fibrillation receiving a direct oral anticoagulant for stroke prevention. Ann Pharmacother. 2025 Dec 26. [Epub ahead of print]. https://doi.org/10.1177/10600280251401892
• Szymanski TW, Rockhold MR, Lacoste JL. Temporal effect of CYP3A4/5 induction on ticagrelor’s pharmacodynamic effects: a case series. J Pharm Pract. 2025;38(1):204-207. https://doi.org/10.1177/08971900241273095
• Teletnick A, Suh K, Boisen M, et al. Evaluating the impact of a standardized protocol for managing refractory vasoplegia after cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 2026 Feb 6. [Epub ahead of print]. https://doi.org/10.1053/j.jvca.2026.02.003
• Zhang L, Li X, Andersson T, Kote A, Yang M, Lee PT, Tisdale JE, et al. A female-specific rabbit model of heart failure with preserved ejection fraction. Heart Rhythm 2025;23(3):E476-E485. [Epub ahead of print]. https://doi.org/10.1016/j.hrthm.2025.11.034
• Rali A, Roberts AD, Blumer V, Bhardwaj A, Rajagopalan N, Nayak A, Hall S, Tunney R, et al. A critical care cardiology perspective on managing acute emergencies in patients with durable ventricular assist devices. J Am Coll Cardiol. 2026 Mar 4. [Epub ahead of print]. https://doi.org/10.1016/j.jacc.2025.11.054

 Presentations

• Maya Chilbert: Minimizing harm, maximizing benefit: safe antithrombotic therapy in older adults. Presented at: 2025 ACCP Annual Meeting; October 18, 2025; Minneapolis, MN.
• Jim Coons: Opportunities and initiatives to improve affordability: the future. Cost of novel heart failure: is the juice worth the squeeze? Presented at: Heart Failure Society of America Annual Meeting; September 2025; Minneapolis, MN.
• Rob DiDomenico:
  • Guidelines meet geography: the relationship between social deprivation index and GDMT quality. Presented at: 2025 ACCP Annual Meeting; October 2025; Minneapolis, MN.
  • ATTR-CM in the U.S.: patterns of healthcare use and medical costs. Poster presented at: AHA Scientific Sessions 2025; November 2025; New Orleans, LA.
  • Polypharmacy and potential for drug-drug interactions among patients with ATTR-CM initiating treatment with tafamidis. Poster presented at: 75th Annual ACC Scientific Session & Expo Poster Session; March 2026; New Orleans, LA.
• Cait Gibson:
  • Curricular evolution: comparison of the last three ACCP toolkits in a doctor of pharmacy curriculum. Presented at: American Society of Health-System Pharmacists Midyear Clinical Meeting; December 2025; Las Vegas, NV.
  • Patients as teachers of interprofessional cultural humility: perspectives of students and patients. Presented at: Patient’s Voice Conference; November 2025; Vancouver, British Columbia, Canada.
  • Assessment of kidney function equations taught in a didactic doctor of pharmacy curriculum. Presented at: 2025 ACCP Annual Meeting; October 2025; Minneapolis, MN.
  • Education abroad: a transformative learning experience for pharmacy students. Presented at: International Pharmaceutical Federation (FIP) 2025 Global Congress; September 2025; Copenhagen, Denmark.
• Alejandro Perez, Madeline Ganter, William Baker, Ian Hollis: Perez AD, Ganter MC, Bova TL, Lewis KM, Poythress KE, Warner ML, Baker WL, Hollis IB. Study protocol: impact of contemporary guideline-directed medical therapy on partial myocardial recovery and clinical outcomes in HeartMate 3 left ventricular assist device patients. Presented at: 2025 ACCP Annual Meeting; October 20, 2025; Minneapolis, MN.
• Kelly Rogers, Kazuhiko Kido, Toby Trujillo, Ashley Schenk: Rogers KC, Kido K, Trujillo TC, Schenk AR. Don’t miss a beat: guideline updates in cardiology. Presented at: 2025 ACCP Annual Meeting; October 19, 2025; Minneapolis, MN.
• Ashley Schenk: Perioperative cardiovascular management for noncardiac surgery. Presented at: ASHP Midyear Clinical Meeting; December 9, 2025; Las Vegas, NV.

New ACCP Fellows

• Ed Horn
• Phil King
• Yee Ming Lee
• Zachary Noel

Other Notable Achievements

• Laura Andino:
  • BCCP.
  • Associate of the American College of Cardiology (AACC).
• Rob DiDomenico: Chair-Elect, American Heart Association Council on Clinical Cardiology Clinical Pharmacology Science Committee.
• Julie Ehret: Associate of the American College of Cardiology (AACC).
• Christie Schumacher: Appointed to the American Diabetes Association (ADA) Professional Practice Committee, which is responsible for writing and updating the ADA Standards of Care (term for 2027 and 2028 Standards).
• Andrew Teletnick: BCCP.

Central Nervous System PRN

Promotions

• Farah Khorassani: Vice Chair of Revenue Generating Program Development at UCI SPPS in the Department of Clinical Pharmacy Practice, Irvine, CA.
• Marisa Rinehart: Clinical Pharmacist Specialist, Atrium Health Wake Forest Baptist Medical Center, Winston-Salem, NC.

Awards

• Ian McGrane: Pannonia Scholarship Programme; University of Montana awardee for Research Mobility to the University of Pécs, Hungary; May 11-14, 2026.

Grants

• Ian McGrane (Co-PI): Tolerability and Dosing of Amphetamine-Based Psychostimulants When Co-prescribed with or without a Strong CYP450 2D6 Inhibiting Antidepressant: A Retrospective Review. Montana Clinical and Translational Research Center: Partner Organization Mini-Grant. Co-Principal Investigator ($5000).

Publications

• Khorassani F, Espejo G, Lee KC. Obstetric outcomes with second-generation long-acting injectable versus oral antipsychotics. J Clin Psychiatry. 2025;87(1):25m16033. https://doi.org/10.4088/JCP.25m16033
• Laswell E, Peterson K, Duan H, Grinalds M. Rapid administration of antiseizure medications: review of safety, effectiveness, and implications for pharmacy practice. Am J Health Syst Pharm. 2026;83(4):131-150. https://doi.org/10.1093/ajhp/zxaf214
• McGrane IR, Hemmer S, Allen D. Electronic pharmaceutical claims data for medication reconciliation processes. Am J Health Syst Pharm. 2025 Dec 30. [Epub ahead of print]. https://doi.org/10.1093/ajhp/zxaf361

Other Notable Achievements

• Farah Khorassani: AAPP Fellow.

Clinical Administration PRN

Promotions

• Amilda Medina: Triad Region Supervisor of Kernersville Medical Center, Medical Park Hospital, and Float Pool Pharmacy, Novant Health. Winston-Salem, NC.

Publications

• Olson JL, Williamson B, Thompson J, Hays E. Implementation of a novel ambulatory care pharmacist training program to facilitate redeployment of community pharmacists. Am J Health Syst Pharm. 2025 Nov 8. [Epub ahead of print]. https://doi.org/10.1093/ajhp/zxaf284

Presentations

• Olson JL:
  • Stacking the deck: population health workflows & metrics. Presented at: ASHP Midyear Clinical Meeting; December 2025; Las Vegas, NV.
  • Betting on primary care transformation: pharmacists leading the way in value-based care. Presented at: ASHP Midyear Clinical Meeting; December 2025; Las Vegas, NV.

Other Notable Achievements

• Richard Artymowicz: Delegate for New Jersey, American Society of Health-System Pharmacists.
• Jeff Olson: Fellow of the American Society of Health-System Pharmacists (FASHP).
• Yujing Steenwyk: President, North Central Society of Florida Society of Health-System Pharmacists.

Community-Based PRN

Publications

• Pastakia SD, Clark A, Lewis K, Taugher D, Adeoye-Olatunde O, et al. Impact of philanthropic investment on integrating social determinants of health into diabetes care at US federally qualified health centers. Dialogues Health. 2025;7:100248. https://doi.org/10.1016/j.dialog.2025.100248
• Edwards KL, Allen RA, Strachan DA, Stover KR, Hughes J. Adapting the pharmacists’ patient care process for faculty to effectively support and meet student needs. Am J Pharm Educ. 2025;89(8):101444. https://doi.org/10.1016/j.ajpe.2025.101444
• Daly CJ, Iqbal DN, Chen EL, et al. Implementing a community health worker model to address health-related social needs in a community pharmacy network: a pragmatic evaluation. J Am Pharm Assoc (2003). 2025;65(6):102490. https://doi.org/10.1016/j.japh.2025.102490
• Daly C, Iqbal DN, Finke JB, Coley KC, Doucette WR, Ferreri SP, Herbert SMC, Jacobs DM, McDonough R, Somma McGivney MA, Nuffer W, Smith MG, Bacci JL. Implementing payer partnerships for patient care programs within clinically integrated networks of community pharmacies: a qualitative study. J Am Pharm Assoc (2003). 2026;66(1):102951. https://doi.org/10.1016/j.japh.2025.102951
• Cellino CAK, Chen EL, Pawelek J, Daly CJ, Jacobs DM, Prescott GM. Pharmacist’s role in addressing barriers to continuous glucose monitoring within underserved communities. J Am Pharm Assoc (2003). 2026;66(2):103016. https://doi.org/10.1016/j.japh.2025.103016
• Eddy E, Ballou J. Assigned mentor to chosen “friend-tor”: the benefits of prolonged mentor relationships. Pulses. A Pharmacy Teaching and Learning Scholarly Blog. November 2025. https://pulsesrx.com/2025/11/06/assigned-mentor-to-chosen-friend-tor-the-benefits-of-prolonged-mentor-relationships/
• Lee S, Eddy E. Optimizing isotretinoin therapy: conventional regimens and new approaches. Pharmacy Times. November 2025. https://www.pharmacytimes.com/view/optimizing-isotretinoin-therapy-conventional-regimens-and-new-approaches
• Davies A, Rudisell E, Ballou J, Hite P, Fabel PH, Hastings TJ. Barriers, facilitators, and confidence to provide maternal health services in pharmacies in South Carolina. J Am Pharm Assoc. 2026;66(1):102996. https://doi.org/10.1016/j.japh.2025.102996
• Ferreri SP, Jahjah KA, Bach AT, et al. Key elements of practice redesign in community pharmacies: report of the 2024-2025 AACP Professional Affairs Standing Committee. Am J Pharm Educ. 2025;89(8):101453. https://doi.org/10.1016/j.ajpe.2025.101453
• Ferreri SP, Ngo P, Yen KD, Wang K, Hughes TD. Examining rural community pharmacists’ knowledge and practices in opioid overdose prevention and treatment services in the southeastern United States. Harm Reduct J. 2026;23(1):11. https://doi.org/10.1186/s12954-025-01364-z
• Busby-Whitehead J, Ferreri SP, Niznik J, et al. A pharmacist consultant service for deprescribing opioids and benzodiazepines in older adults: a cluster randomized trial. JAMA Netw Open. 2026;9(2):e2560581. https://doi.org/10.1001/jamanetworkopen.2025.60581
• Nowak J, Hughes TD, Sottung E, Ferreri SP. Examining structural characteristics for implementing opioid use disorder services in community-based pharmacies. J Am Pharm Assoc (2003). 2025;65(5):102425. https://doi.org/10.1016/j.japh.2025.102425
• Carroll JC, Herbert SMC, Coley KC, Nguyen TQ, McGivney MAS, et al. “Let’s Talk Stigma”: a pharmacy-based program for opioid use disorder anti-stigma education in Pennsylvania. Pharmacy (Basel). 2025;14(1):3. https://doi.org/10.3390/pharmacy14010003
• Iqbal DN, Daly CJ, Anderson J, et al. Perceptions and attitudes of health-related social needs program facilitators within community pharmacies: a mixed methods study. J Am Pharm Assoc (2003). 2025;65(5):102446. http://doi.org/10.1016/j.japh.2025.102446
• Hsu H, Iqbal D, Feuerstein S, Paul D, Wahler RG, Daly CJ, et al. Z-code health-related social needs and their association with post-discharge healthcare utilization in older adults with heart failure and COPD. J Gen Intern Med. 2025 Oct 23. [Epub ahead of print]. https://doi.org/10.1007/s11606-025-09887-8
• Jeon M, Lingow S. Skin care and minor dermatologic conditions. In: Haines ST, Nolin TD, Ellingrod VL, et al, eds. DiPiro’s Pharmacotherapy: A Pathophysiologic Approach. 13th ed. McGraw Hill; 2026.
• Bien-Gund CH, Sweeney A, Ptak B, Jeon M, et al. Implementation determinants of HIV testing and pre-exposure prophylaxis in community pharmacies in Philadelphia, PA. AIDS Patient Care STDS. 2025;39(9):353-362. https://doi.org/10.1177/10872914251365540
• Lahrman R, Marley G. Clarifying pharmacy wholesaler threshold limits: impact on buprenorphine access in rural communities. J Am Coll Clin Pharm. 2026;9(2):e70184. https://doi.org/10.1002/jac5.70184
• Hill L, Kissel J, Pauvlinch P, Seifert J, Lahrman R. Description and impact of a community pharmacy-based collaborative practice agreement. J Am Pharm Assoc (2003). 2026;66(1):102998. https://doi.org/10.1016/j.japh.2025.102998
• Longenecker A, Buxton J, Logue S, Ocana E, Marciniak MW, Rhodes LA. Assessing the impact of certified pharmacy technicians on behavioral health care management. JAPhA Pract Innov. 2026 Feb 11. [Epub ahead of print]. https://doi.org/10.1016/j.japhpi.2026.100101
• Whitfield C, Baird A, Abode A, Marciniak MW, Rhodes LA. Evaluating provider satisfaction with the role of clinical pharmacists delivering chronic care management services within an accountable care organization. JAPhA Pract Innov. https://doi.org/10.1016/j.japhpi.2026.100100
• Carpenter DM, Stover A, Shackley AG, Tudor G, Cross W, Marley G, et al. The impact of an online suicide prevention training program on community pharmacy staff outcomes: a cluster randomized trial. J Am Pharm Assoc (2003). 2026;66(3):103038. https://doi.org/10.1016/j.japh.2026.103038
• Shubel C, Nunnery MA, Marley G, Ostract B, Carpenter DM. Barriers and facilitators to methadone dispensing for opioid use disorder in community pharmacies: a scoping review. Drug Alcohol Depend Rep. 2026;18:100413. https://doi.org/10.1016/j.dadr.2026.100413
• Miller EE, Ahmed P, Middendorf AW, Van Gilder D, Amell JW, Snyder ME. A pharmacist-led mobile pop-up clinic: development and pilot implementation outcomes. J Am Pharm Assoc (2003). 2026;66(1):102975. https://doi.org/10.1016/j.japh.2025.102975
• Yen KD, Shook AK, Marciniak MW, Rhodes LA. College student attitudes and perceptions toward opioid overdose and harm reduction at a large public university. JAPhA Pract Innov. 2025 Dec 26. [Epub ahead of print]. https://doi.org/10.1016/j.japhpi.2025.100090

 Presentations

• Ferreri SP. Envisioning the future of community pharmacy: key elements of practice management. Presented at: 2025 ACCP Annual Meeting; October 2025; Minneapolis, MN.
• Jeon M, Sulicz E. From science to shots: path to vaccine approval, clinical updates, and safety reporting. Presented at: Pennsylvania Pharmacists Association Eastern Regional Meeting; October 2025; Philadelphia, PA.
• Kane-Gill S, Trinkley KE, McLaughlin J, Snyder ME. AI-powered research: a hands-on guide for pharmacists. Presented at: 2025 ACCP Annual Meeting; October 2025; Minneapolis, MN.

Other Notable Achievements

• Emily Eddy: Appointed Social Media Coordinator for Pulses, a Pharmacy Teaching and Learning Scholarly Blog.
• Rebecca Lahrman: Appointed to the Research Affairs Committee for ACCP.

Critical Care PRN

Promotions

• Leslie Hamilton: Health System Experiential Learning Coordinator, University of Tennessee Health Science Center College of Pharmacy, Memphis, TN.

Awards

• Leslie Hamilton: Presidential Citation Award, Society of Critical Care Medicine.
• Jerika Nguyễn: Service Excellence Award, ACCP Health Equity PRN.

Grants

• Jenna Cox: AI-Enabled Models for Predicting Cardiac Events in Patients on QT-Prolonging Medications. SC EPSCoR (South Carolina Established Program to Stimulate Competitive Research). Consultant/Co-Investigator ($12,777 Hospital Subaward/$70,000 Total Award).
• Mojdeh Heavner: Optimizing Opioid Therapy in Hospitalized Internal Medicine Patients: A Pharmacist-Led Medication Stewardship Initiative. American Society of Health-System Pharmacists Foundation Resident Research Grant. Senior Investigator ($5000).
• Susan Smith (Principal Investigator), Andrea Sikora, Brian Murray, Kelli Henry, Mojdeh Heavner, Xianyan Chen (Co-Investigators): Data-Guided Workload Distribution to Improve ICU Patient Outcomes and Healthcare Worker Well-Being. Society of Critical Care Medicine Discovery Grant ($100,000).

Publications

• Amer M, Al Mubayedh HO, Bolesta S, Gélinas C. Analgesia first in critically ill adults: current practices and future directions. Crit Care Clin. 2025;41(4):683-705. https://doi.org/10.1016/j.ccc.2025.05.002
• Paytes E, Mefford B, Love B, Amick A, Cox J. Impact of intravenous hydrocortisone on postoperative atrial fibrillation and outcomes in patients receiving vasopressor support following on-pump coronary artery bypass grafting. Hosp Pharm. 2025 Dec 17. [Epub ahead of print]. https://doi.org/10.1177/00185787251381597
• Chase A, Most A, Xu S, Barreto E, Murray B, Henry K, Smith S, Hedrick T, Chen X, Li S, Liu T, Sikora A. Large language models management of complex medication regimens: a case-based evaluation. Front Pharmacol. 2025;16:1514445. https://doi.org/10.3389/fphar.2025.1514445
• Bastin MLT, Rech MA, Betthauser KD, Heavner MS, Horng M, Lemieux SM, Lumpkin M, McCreary EK, Ruggero MA, et al. Impact of beta-lactam antibiotic renal dose adjustment on clinical outcomes in patients with septic shock and acute kidney injury from gram-negative bloodstream infections: a multicenter observational study. CMI Commun. 2025;2(3):105084. https://doi.org/10.1016/j.cmicom.2025.105084
• Cook AM, Harris M, Michas C. Pharmacist’s guide to common intracranial bleeding terms and treatments. Ann Pharmacother. 2026;60(2):181-195. https://doi.org/10.1177/10600280251358676
• Kharouba M, Cook AM, Bastin MLT, Kutsogiannis DJ, Mahmoud SH. Levetiracetam dosing optimization in neurocritical care population: Neuro-ARC study. Neurocrit Care. 2025;43(3):887-901. https://doi.org/10.1007/s12028-025-02347-5
• Rosewarne RE, Farina N. Thiamine use in hospitalized patients: a clinical review. J Nutr Metab. 2026;2026:7143046. https://doi.org/10.1155/jnme/7143046
• Forehand CC, Benken ST, Madorsky M, Mohamed A, Nguyễn JV, Dixit D, Gallagher J, Hawkins WA, Heavner MS, Johnson E, Lozano L, Sisco M, Slampak-Cindric AA, Smith SE, Spezzano K, Taylor BA 2nd, Wayne NB, et al. Pharmacotherapeutic controversies during temperature control after out-of-hospital cardiac arrest: a semi-structured literature review. Pharmacotherapy. 2026;46(1):e70095. https://doi.org/10.1002/phar.70095
• Hamilton LA. Seizure disorders. The APhA Complete Review for Pharmacy. 14th ed. American Pharmacists Association; 2026.
• Wallhauser HM, Hamilton LA, Brown SR, Christianson TJ, Wiseman B, Bray ON, Caldwell HW, Rowe AS. Association between insulin dose and hyperglycemia in hospitalized adults with ischemic stroke on continuous enteral nutrition: a retrospective cohort study. J Parenter Enteral Nutr. 2025;49(6):752-757. https://doi.org/10.1002/jpen.2787
• Heavner MS, Heavner JJ, Murray B, Sikora A. Response to comment on “Consensus recommendations for the integration of critical care pharmacists on intensive care unit teams: endorsed by the American Association of Critical-Care Nurses, American College of Clinical Pharmacy, American Society of Health-System Pharmacists, Institute for Safe Medication Practices, and Society of Critical Care Medicine.” J Am Coll Clin Pharm. 2025;8(10):1103-1104. https://doi.org/10.1002/jac5.70116
• Heavner MS, Henry K, Sikora A, Smith SE; OPTIM Investigator Team. Optimizing pharmacist team-integration for ICU patient management (OPTIM): recruitment and retention strategies to mobilize a professional community. J Am Coll Clin Pharm. 2026;9(2):e70154. https://doi.org/10.1002/jac5.70154
• Ejutse O, D’Aiuto C, Heavner MS, Bell CM. Beyond the error: confronting second victim syndrome in health-system pharmacy practice. Am J Health Syst Pharm. 2026;83(4):211-215. https://doi.org/10.1093/ajhp/zxaf275
• Jacobi J. Foreword. In: Alzaidi Y, Abdelzaher M, eds. The Pharmacist’s Expanded Role in Critical Care Medicine: A Comprehensive Guide for Practitioners and Trainees. Springer Nature; 2025.
• Jacobi J. Rethink, relearn, repeat. Many things I thought I knew—but didn’t. J Am Coll Clin Pharm. 2026;9(2):e70152. https://doi.org/10.1002/jac5.70152
• Hidalgo JL, Kumar VK, Akech SO, Myatra SN, Jacob ST, Kortz T, Vasquez AA, Bazzano MCJ, Diaz M, Rodríguez JDR, Garcia ALN, Giron R, Jacobi J, et al. The sepsis chain of survival: a comprehensive framework for improving sepsis outcomes. Crit Care Med. 2025;53(10):e1886-1892. https://doi.org/10.1097/CCM.0000000000006796
• Kenes MT, Farina N. Fluid resuscitation in the intensive care unit. In: Alzaidi Y, Abdelzaher M, eds. The Pharmacist’s Expanded Role in Critical Care Medicine: A Comprehensive Guide for Practitioners and Trainees. Springer Nature; 2025.
• Govalan R, Hao S, Kenes MT, McSparron JI, Tapper EB. Safety and effectiveness of phenobarbital vs benzodiazepines for severe alcohol withdrawal in alcohol-associated liver disease in the ICU. JHEP Rep. 2026 Feb 4. [Epub ahead of print]. https://doi.org/10.1016/j.jhepr.2026.101769
• Hooper L, Heung M, Wang L, Matvekas A, Alikhani R, Kenes MT, et al. Pharmacokinetic characterization of iopamidol and iohexol for optimizing measured glomerular filtration rate assessment in clinical practice and drug development. J Clin Pharmacol. 2025;65(11):1350-1361. https://doi.org/10.1002/jcph.70046
• Krenz Z, Bennett A, Hall K, Phillips T, Henry K. Impact of a standardized nurse-driven bowel regimen on bowel frequency in critically ill patients. Nurs Crit Care. 2025;30(6):e70207. https://doi.org/10.1111/nicc.70207
• Martirosov AL, Abdalla M, Fleischman ME, Foster B, Gonzales J, Lipari M, Malesker M, Smith Z, et al. Navigating the alphabet soup of interstitial lung diseases (ILD): the role of pharmacists. J Am Coll Clin Pharm. 2025;8:1027-1045. https://doi.org/10.1002/jac5.70089
• Orchard J, Caffarini E, Harding A, Schuler A, Lockhart MM, Dillis J, Meester A. Impact of initial heparin rates on reaching goal anti-Xa and activated partial thromboplastin time within 48 hours of initiation in patients with mechanical circulatory support. J Pharm Pract. 2026 Jan 16. [Epub ahead of print]. https://doi.org/10.1177/08971900261417915
• Rowe AS, Wiseman B, Hamilton LA, et al. Safety of tenecteplase in stroke mimics compared with acute ischemic stroke: a retrospective cohort study. Pharmacotherapy. 2026 Jan 22. [Epub ahead of print]. https://doi.org/10.1002/phar.70112
• Shoulders BR, Casapao AM, Johnson S, Patel P, Alexander KM. Enhancing CV writing through AI-guided interviews. Am J Pharm Educ. 2025;89(11):101627. https://doi.org/10.1016/j.ajpe.2025.101627
• Shoulders BR, Fassler AM, Maguigan KL, et al. Short-course antibiotic agent therapy for early ventilator-associated pneumonia in patient with trauma. Surg Infect (Larchmt). 2025;26(10):725-731. https://doi.org/10.1177/10962964251376956
• Sikora A, Murray B, Henry K, Smith SE, Buckley MS, Campbell R, Dixit D, Dzierba AL, Hass CE, Heavner MS, Heavner JJ, Iademarco MF, Jew R, Johnson PN, Kane-Gill S, Martin GS, Palm N, Reed BN, Seckel MA, Steffenhagen A, Smith Z. Consensus recommendations for the integration of critical care pharmacists on intensive care unit teams: endorsed by the American Association of Critical-Care Nurses, American College of Clinical Pharmacy, American Society of Health-System Pharmacists, Institute for Safe Medication Practices, and Society of Critical Care Medicine. J Am Coll Clin Pharm. 2025;8(9):914-930. https://doi.org/10.1002/jac5.70084
• Kabalka E, Smith Z, Tatem G, August B. Critically ill patients with severe cirrhosis receiving dexmedetomidine at a higher risk of cardiovascular instability: application of an objective novel cirrhosis scoring system. J Intensive Care Med. 2025 Dec 22. [Epub ahead of print]. https://doi.org/10.1177/08850666251408751
• Mabie K, Smith BA, Chase A, Henry KR. Evaluation of desmopressin in preventing overcorrection of hyponatremia among patients with renal dysfunction. Eur J Hosp Pharm. 2025 Dec 30. [Epub ahead of print]. https://doi.org/10.1136/ejhpharm-2025-004693

 New ACCP Fellows

• Kara L. Birrer
• Brittany D. Bissell Turpin
• Brian W. Gilbert
• Christine M. Groth
• Anthony Hawkins
• Michael T. Kenes
• Susan E. Smith

Other Notable Achievements

• Aeryana Bektas:
  • Vice Chair, ACCP Critical Care PRN Recognition Committee.
  • Chair-Elect, SCCM CPP Membership Committee.
• Sarah Blackwell: President-Elect, Alabama Society of Health-System Pharmacists.
• Paige Bradshaw: Ohio Delegate, American Society of Health-System Pharmacists.
• Aaron Cook: Chair, ACCP Educational Affairs Committee.
• Jenna Cox: President, SCCM Carolinas/Virginias Chapter.
• Leslie Hamilton: Appointed Member, AACP Rufus A. Lyman Award Committee.
• Kelli Henry: Charge Lead, ACCP Critical Care PRN Membership Committee Mentorship Program.
• Judi Jacobi:
  • Past-President, SCCM Midwest Chapter.
  • Speaker, 2025 ACCP Annual Fellows Dinner Address.
• Jerika Nguyễn: Chair-Elect, ACCP Health Equity PRN.
• Jordan Orchard: BCCCP.

Drug Information PRN

 Awards

• Audrey Kostrzewa: American Public Health Association (APHA) Pharmacy Section Sustained Contributor Award (national, 11/2025).

Publications

• Abdalla M, Saad M, Abazia A, Advani A, Alhammad A, Bernknopf A, Bitra V, Blommel ML, Conn K, Goldwire M, Gosser R, Iso T, Johnson S, Kier KL, Kostrzewa A, Majerczyk D, Munir F, Phillips J, Segovia M, Sibbesen J, Sehman M, Sommer CD, Stark J, Thornby K. Responsible use of artificial intelligence in health care: evidence, challenges, and best practices: an opinion of the Drug Information Practice and Research Network of the American College of Clinical Pharmacy. J Am Coll Clin Pharm. 2025;8(12):1333-1361. https://doi.org/10.1002/jac5.70131
• Coley AK, Anweiler MA, Wallace BM, Brown JN. Scholarship outcomes and opportunities of a medical writing rotation for pharmacy residents. J Am Coll Clin Pharm. 2026;9(2):e70157. https://doi.org/10.1002/jac5.70157
• Johnson ST, Cook K, Dallmeier J, Heuett N, Barker K. Hospital price transparency: a primer. Am J Health Syst Pharm. 2026 Jan 23. [Epub ahead of print]. https://doi.org/10.1093/ajhp/zxag022
• Lee KC, Haines S, Gable KN, Bruce SP, Kostrzewa A, et al. Exploration of psychosocial hazards: job demands, rewards and recognitions, and autonomy to address workforce well-being. Am J Pharm Educ. 2025;89(8):101459. https://doi.org/10.1016/j.ajpe.2025.101459
• Sibbesen JB, Trickett H, Yzaguirre S. An evaluation of size artificial intelligence tools for formulary management. J Am Coll Clin Pharm. 2026;(9)2:e70172. https://doi.org/10.1002/jac5.70172
• Thornby KA, Cain J. Balancing autonomy and accountability through curricular flexibility in pharmacy education. Am J Pharm Educ. 2025;89(10):101865. https://doi.org/10.1016/j.ajpe.2025.101865
• Rhoney DH, Chen AMH, Chung E, Churchwell MD, Daugherty KK, Kleppinger EL, Nelson NR, Parker D, Sibicky SL, Stowe CD, Thornby KA, et al. Behavioral foundations for CBPE: using the BCW to advance individual readiness to change. Am J Pharm Educ. 2025;89(9):101470. https://doi.org/10.1016/j.ajpe.2025.101470
• Rhoney DH, Chen AMH, Thornby K, et al. Assessing the current state of pharmacy education: a strengths-weaknesses-opportunities-threats analysis. Am J Pharm Educ. 2026;90(1):101898. https://doi.org/10.1016/j.ajpe.2025.101898
• Rhoney DH, Daugherty KK, Chen AMH, Churchwell M, Sibicky S, Thornby K, et al. A unifying vision for pharmacy: defining professional identity through stakeholder perspectives. J Am Pharm Assoc. 2026;66(2):103013. https://doi.org/10.1016/j.japh.2025.103013
• Rhoney DH, Daugherty KK, Chen AMH, Kleppinger EL, Churchwell M, Thornby K, et al. The hidden architecture of inertia: stakeholder perspectives on the most pressing challenges in pharmacy education. Am J Pharm Educ. 2026;90(1):101899. https://doi.org/10.1016/j.ajpe.2025.101899
• Rhoney DH, Daugherty KK, Chen AMH, Nelson N, Thornby K, et al. From strength to struggle: stakeholder insights into the readiness of tomorrow’s pharmacists. Am J Pharm Educ. 2026;90(1):101900. https://doi.org/10.1016/j.ajpe.2025.101900

Other Notable Achievements

• Audrey Kostrzewa: Drug Information and Library Science (DILS) Section Chair, American Association of Colleges of Pharmacy.
• Julie Sibbesen:
  • Drug Information PRN Chair-Elect, ACCP.
  • Ambulatory Subcommittee of Enterprise Pharmacy & Therapeutics Vice Chair, WVU Medicine.

Education and Training PRN

Promotions

• Mariann Churchwell: Professor, University of Toledo College of Pharmacy and Pharmaceutical Sciences.
• Kelly Cochran: Adjunct Clinical Professor, University of Missouri-Kansas City School of Pharmacy.
• Deidra Simpson: Professor, Liberty University School of Nursing.
• Bao Anh Tran: Interim Director of Academic Success, USF Taneja College of Pharmacy.
• Sarah Vordenberg: Clinical Professor, University of Michigan College of Pharmacy.

Awards

• Kate Cozart: Student Advocate Award, Tennessee Pharmacists Association.
• Kristin Janzen: Distinguished Young Alumnus Award, UT Austin College of Pharmacy Alumni Association.
• Taylor Steuber: 2025 Adult Medicine PRN Distinguished Investigator Award (ACCP).

Publications

• Boylan PM, Skrepnek G, Neely S, et al. Montelukast deprescribing and neuropsychiatric events in older adults: a cross-sectional descriptive report. Geriatr Pharmacol. 2026;3(1):Article 2621471. https://doi.org/10.1080/2994399X.2026.2621471
• North A, Skrepnek G, Atkins RM, Skaggs J, Wu H, Boylan PM. Comparing ASHP and PQA frameworks for identifying medication therapy problems in older adults with COPD discharged to home health care: a cross-sectional study. Sr Care Pharm. 2026;41(1):34-42. https://doi.org/10.4140/TCP.n.2026.34
• Oldham M, Benavides S, Boylan PM. Navigating measles treatment in 2025: a review on vaccines, medications, and supplements. Pediatr Allergy Immunol Pulmonol. 2025;38(4):113-118. https://doi.org/10.1177/2151321X251397927
• Young J, Novak K, Boylan P. What are alternatives to oral phenylephrine in children? Pediatr Allergy Immunol Pulmonol. 2025;38(3):83-87. https://doi.org/10.1089/ped.2025.0031
• Grant KB, Churchwell MD, Baki G, Howard MS. In-vitro physical compatibility of intravenous doxycycline hyclate and acyclovir sodium. Medtigo J Pharmacol. 2025;2(4):e3061242. https://doi.org/10.63096/medtigo3061242
• Rhoney DH, Chen AMH, Thornby KA, Daugherty KK, Churchwell MD, Kleppinger EL, et al. Assessing the current state of pharmacy education: a strengths-weaknesses-opportunities-threats analysis. Am J Pharm Educ. 2025;90(1):101898. https://doi.org/10.1016/j.ajpe.2025.101898
• Rhoney DH, Daugherty KK, Chen AMH, Churchwell M, et al. A unifying vision for pharmacy: defining professional identity through stakeholder perspectives. J Am Pharm Assoc (2003). 2025;66(2):103013. https://doi.org/10.1016/j.japh.2025.103013
• Rhoney DH, Daugherty KK, Chen AMH, Kleppinger EL, Churchwell MD, et al. The hidden architecture of inertia: stakeholder perspectives on the most pressing challenges in pharmacy education. Am J Pharm Educ. 2025;90(1):101899. https://doi.org/10.1016/j.ajpe.2025.101899
• Rhoney DH, Daugherty KK, Chen AMH, Nelson NR, Thornby KA, Kleppinger EL, Churchwell MD, et al. From strength to struggle: stakeholder insights into the readiness of tomorrow’s pharmacists. Am J Pharm Educ. 2025;90(1):101900. https://doi.org/10.1016/j.ajpe.2025.101900
• Rowell H, Johnson RM, Baki G, Reinert JP, Churchwell MD, Howard MS. Physical compatibility of ceftazidime and ceftazidime/avibactam in 0.45% sodium chloride and Plasma-Lyte A. Int J Pharm Compd. 2025;29(6):453-462.
• Rhoney DH, Chen AMH, Thornby KA, Nelson NR, Daugherty KK, Churchwell MD, et al. Future-proofing pharmacy: a stakeholder-informed forecast of workforce and education needs. J Am Coll Clin Pharm 2026;9(2):e70177. https://doi.org/10.1002/jac5.70177
• Sowinski KM, Churchwell MD. Hemodialysis and peritoneal dialysis. In: Haines ST, Nolin TD, Ellingrod VL, et al, eds. DiPiro’s Pharmacotherapy: A Pathophysiologic Approach. 13th ed. McGraw Hill; 2026.
• Elmes-Patel AT, Jarrett JB, Jimenez AD, Mayer S, Messmer S. Expanding access to opioid use disorder treatment: low threshold buprenorphine dispensing via an interprofessional mobile medical unit in Chicago. J Am Coll Clin Pharm. 2026;9(2):e70170. https://doi.org/10.1002/jac5.70170
• Rains A, Elmes-Patel A, Coffee A, Beeler S, Messmer S. Let the girls know, “you can come here”: qualitative experiences with harm reduction and health services among women who use drugs in Chicago. Harm Reduct J. 2026 Feb 17. [Epub ahead of print]. https://doi.org/10.1186/s12954-026-01423-z
• Shah K, Messmer S, Elmes-Patel A, Touchette DR. Economic analysis of a low-threshold mobile medical unit dispensing buprenorphine for opioid use disorder. J Subst Use Addict Treat. 2026;184:209900. https://doi.org/10.1016/j.josat.2026.209900
• Hanson T, Paloucek F, Elmes-Patel AT. Comment: safety of phenobarbital versus benzodiazepines for alcohol withdrawal in critically ill patients with primary neurologic injuries. Ann Pharmacother. 2026;60(1):93. https://doi.org/10.1177/10600280251351934
• Martinford A, Watson DP, Messmer SM, Rashid LM, Staton M, Dennis ML, Grella CE, Elmes-Patel AT. “Convenience, quickness, and compassion”: experiences of individuals involved in the criminal-legal system accessing buprenorphine from a mobile unit in Chicago. Health Expect. 2026;29(1):e70552. https://doi.org/10.1111/hex.70552
• Bennett A, Murray B, Sikora A, Reynolds E, Branan TN, Bland CM, Hawkins WA, et al. The weight debate: ideal versus total body weight for fluid resuscitation in septic shock. Am J Health Syst Pharm. 2026;83(5):e220-e226. https://doi.org/10.1093/ajhp/zxaf313
• Forehand CC, Benken ST, Madorsky M, Mohamed A, Nguyễn JV, Dixit D, Gallagher J, Hawkins WA, et al. Pharmacotherapeutic controversies during temperature control after out-of-hospital cardiac arrest: a semi-structured literature review. Pharmacotherapy. 2026;46(1):e70095. https://doi.org/10.1002/phar.70095
• Brown B, Schemmel J, Reinert JP, Baki G, Howard MS, Churchwell MD. Physical compatibility of ertapenem and meropenem in 0.45% normal saline and Plasma-Lyte A. Int J Pharm Compd. 2025;29(5):430-434.
• Ammar A, Fardoun H, Hart E, Cagadas E, Tatar B, Ng TH, Janzen KM, Addison JA, Guiliano C. Closing the gap: evaluating the safety and effectiveness of diabetic ketoacidosis nomograms. Ann Pharmacother. 2025 Nov 14. [Epub ahead of print]. https://doi.org/10.1177/10600280251388640
• Laswell E, Peterson K, Duan H, Grinalds M. Rapid administration of antiseizure medications: review of safety, effectiveness, and implications for pharmacy practice. Am J Health Syst Pharm. 2026;83(4):131-150. https://doi.org/10.1093/ajhp/zxaf214
• McDanel DL, Mitri EA, Li JT, Brockow K. Inpatient penicillin allergy evaluation—skin testing versus direct oral challenge? J Allergy Clin Immunol Pract. 2025 Dec 18. [Epub ahead of print]. https://doi.org/10.1016/j.jaip.2025.12.012
• Shoulders BR, Casapao AM, Johnson S, Patel P, Alexander KM. Integrating AI-facilitated interviews to enhance CV writing. Curr Pharm Teach Learn. 2026;18(5):102590. https://doi.org/10.1016/j.cptl.2026.102590
• Shoulders BR, Fassler AM, Maguigan KL, et al. Short-course antibiotic agent therapy for early ventilator-associated pneumonia in patients with trauma. Surg Infect (Larchmt). 2025;26(10):725-731. https://doi.org/10.1177/10962964251376956
• Shoulders BR, Maguigan KL, Lemon SJ. Medication prescribing observations in care transitions for incarcerated patients. Hosp Pharm. 2026 Jan 19. [Epub ahead of print]. https://doi.org/10.1177/00185787251407057
• Simpson D. When a conference becomes a catalyst: how CPFI Annual Meeting became my bridge to medical missions. Christianity and Pharmacy. [In press]
• Richter L, Taylor S, Soric MM. Declining pharmacy student enrollment, its impact on health-system pharmacy, and a call to action. Am J Health Syst Pharm. 2025;82(18):1031-1034. https://doi.org/10.1093/ajhp/zxaf062
• Vergara M, Soric MM, King O, et al. Prescribing patterns of gabapentinoids in patients with chronic obstructive pulmonary disorder. COPD. 2026;23(1):2596683. https://doi.org/10.1080/15412555.2025.2596683
• Barchet AC, Fleming JN, Rydz A, Steuber TD, Thayer BG. Real-world evaluation of a pneumonia PCR panel: appropriateness, outcomes, and antimicrobial stewardship implications. Hosp Pharm. 2025 Dec 1. [Epub ahead of print]. https://doi.org/10.1177/00185787251393063
• Krsak M, Klimpl D, Mueller SW, Morrisette T, Grimshaw AA, Chastain D, Steuber TD, et al. Oritavancin for treatment of osteomyelitis: a systematic review and meta-analysis of observational studies. Pharmacotherapy. 2025;45(11):754-763. https://doi.org/10.1002/phar.70072
• Salvatore D, Moore J, Steuber TD. Long-acting lipoglycopeptides compared to standard-of-care for the treatment of complicated gram-positive infections: a systematic review and meta-analysis. Int J Antimicrob Agents. 2025;66(5):107581. https://doi.org/10.1016/j.ijantimicag.2025.107581
• Stropes A, Lautenschlager C, Smith AJ, Steuber TD, Sperry M. Linezolid versus clindamycin for toxin inhibition in severe skin and soft tissue infections: a systematic review and meta-analysis. Infection. 2026 Jan 8. [Epub ahead of print]. https://doi.org/10.1007/s15010-025-02722-6
• Loeb A, Szwak JA, Sperry JD. Resident perspectives on conducting a multicenter research experience. Am J Health Syst Pharm. 2026;83(suppl 1):S13-S19. https://doi.org/10.1093/ajhp/zxaf253
• Tran BAC, Wantuch GA, Mangasar M, Miranda AC. Battle of the (chat)bots: comparative evaluation of April 2025 AI model accuracy on pharmacotherapeutic cases. Am J Pharm Educ. 2026;90(1):101922. https://doi.org/10.1016/j.ajpe.2025.101922
• Wright SS, Wright C. The importance of medication reconciliation in a patient with Parkinson’s disease. Sr Care Pharm. 2025;40(11):443-449. https://doi.org/10.4140/TCP.n.2025.443

Presentations

• Boylan P. From echinacea to evidence: herbals and supplements for cold and flu season. Presented at: The Walter P. Scheffe Continuing Pharmaceutical Education Series; November 2025; Oklahoma City, OK.
• Chilbert MR, Linnebur S, Ernst M. Minimizing harm, maximizing benefit: safe antithrombotic therapy in older adults. Presented at: 2025 ACCP Annual Meeting; October 2025; Minneapolis, MN.
• Mariann D. Churchwell:
  • Unlocking competency-based pharmacy education (CBPE): an interactive escape room experience. Presented at: American Association of Colleges of Pharmacy Annual Meeting; July 2025; Chicago, IL.
  • Mapping the journey to practice-readiness: building a competency roadmap in pharmacy education. Presented at: American Association of Colleges of Pharmacy Annual Meeting; July 2025; Chicago, IL.
  • AACP pearls. Presented at: University of Toledo College of Pharmacy and Pharmaceutical Sciences Faculty Development Series; September 2025; Toledo, OH.
  • Bridging the gap: applying competency-based pharmacy education to resident growth. Presented at: Ohio Society of Health-System Pharmacists Annual Meeting; October 2025; Columbus, OH.
  • Bridging the gap: applying competency-based pharmacy education to resident growth. Presented at: University of Toledo College of Pharmacy and Pharmaceutical Sciences Preceptor Development; December 2025; Toledo, OH.
• Coffee AN, Gianos M, Knock M, Martinford T, Elmes-Patel A. Preferred terminology of individuals who engage with harm reduction and medications for opioid use disorder services. Presented at: American Society of Health-System Pharmacists (ASHP) Annual Meeting; December 2025; Las Vegas, NV.
• Coffee AN, Messmer S, Jimenez, AD, Mayer S, Murphy A, Patel C, Gassam A, Martinford A, Elmes-Patel A. Low-barrier, high impact: a four-year retrospective analysis of outreach and impact of mobile units for opioid use disorder in Chicago. Presented at: 2025 ACCP Annual Meeting; October 2025; Minneapolis, MN.
• Coffee AN, Stranges P, Keller E, Infante A, Martinford T, Rashid L, Elmes-Patel AT. Patient factors associated with hospital discharge on buprenorphine versus methadone. Presented at: 2025 ACCP Annual Meeting; October 2025; Minneapolis, MN.
• Kate Cozart:
  • Compassion: cultivating the worldwide wonder drug. Presented at: Phi Lambda Sigma Leadership Summit; September 2025; virtual.
  • Confidence in care: supporting Gen Z learners to overcome impostor phenomenon in the patient care setting. Presented at: VA National Preceptors and RPD Virtual Conference; September 2025; virtual.
  • Navigating the storms of self doubt without burning out. Presented at: Belmont SSHP-ASHP General Body Meeting; October 2025; Nashville, TN.
  • Paving the way for better communities: treating alcohol use disorder. Presented at: Tennessee Association of Recovery Court Professionals; December 2025; Murfreesboro, TN.
  • Federal burnout: why it happens & what we can do. Presented at: ASHP Midyear Federal Forum; December 2025; Las Vegas, NV.
• Abigail Elmes-Patel:
  •  “It’s like playing Russian roulette”: perceptions of negative consequences of drug use among a sample of women who use drugs seeking harm reduction services. Presented at: Society for Social Work and Research Annual Conference; January 2026; Washington, DC.
  • “The lowest strip wasn’t going to work for me”: rapid overlap initiation versus standard initiation of buprenorphine in a mobile van. Presented at: Association for Multidisciplinary Education and Research in Substance Use and Addiction (AMERSA) Annual Conference; November 2025; Portland, OR.
  • Stakeholder perspectives on expanding mobile opioid use disorder treatment services to reach non-urban communities. Presented at: Association for Multidisciplinary Education and Research in Substance Use and Addiction (AMERSA) Annual Conference; November 2025; Portland, OR.
• Knock M, Patel A, Hernandez R, Behpour B, Elmes-Patel A. Assessing availability of buprenorphine/naloxone films in Illinois community pharmacies post X-waiver removal: a secret shopper survey. Presented at: American Society of Health-System Pharmacists Annual Meeting; December 2025; Las Vegas, NV.
• Simpson D. Leaving implicit bias at the door. Presented at: Virginia Student Nurses’ Association Annual Meeting; February 2026; Radford, VA.

New ACCP Fellows

• Anthony Hawkins

Other Notable Achievements

• Ellen Jones: Recently launched 2 pharmacy learning applications, Phluent and Phormula. Phluent.app is a Duolingo-like app for developing pharmacology fluency, where users can practice spelling, pronunciation, and foundational pharmacology information using a gaming structure. Phormula is an online tool for practicing pharmacy calculations, with available structured learning and AI-powered tutoring.

Emergency Medicine PRN

Promotions

• Nicole Acquisto: Professor, Department of Emergency Medicine, University of Rochester School of Medicine & Dentistry, Rochester, NY.
• Kyle Weant:
  • Clinical Assistant Professor, University of South Carolina School of Medicine Greenville, Greenville, SC.
  • Research Program Coordinator, Department of Emergency Medicine, Medical University of South Carolina, Charleston, SC.
• Sarah Wright: Clinical Pharmacist II, Baptist Health – North Little Rock, North Little Rock, AR.

Awards

• Nicole Acquisto:
  • Top 10 Most Cited Papers Published by the Journal of the American College of Clinical Pharmacy for: Bondi DS, Acquisto NM, Buckley MS, et al. Rewards, recognition, and advancement for clinical pharmacists. J Am Coll Clin Pharm. 2023;6:427-439. https://doi.org/10.1002/jac5.1775
  • Top Viewed Article in Journal of the American College of Clinical Pharmacy for: Bondi DS, Acquisto NM, Buckley MS, et al. Rewards, recognition, and advancement for clinical pharmacists. J Am Coll Clin Pharm. 2023;6:427-439. https://doi.org/10.1002/jac5.1775
• Jerika Nguyễn-Klatt: Service Excellence Award, ACCP Health Equity PRN.
• Megan Rech:
  • Top Peer Reviewer Award, Annals of Emergency Medicine.
  • Presidential Citation Award, Society of Critical Care Medicine.
  • Editor’s Choice Award, American College of Clinical Pharmacy, for: Smetana KS, Flannery AH, Gurnani PK, Peppard WJ, Patel MAVB, Joyce C, Rech MA. PHarmacist avoidance or reductions in medical costs in CRITically ill adults rounding with one SERVICE compared to two or more services: PHARM-CRIT-SERVICE. J Am Coll Clin Pharm. 2023;6(9):1000-1007. https://doi.org/10.1002/jac5.1798
  • Paper of the Year, Original Research Emergency Medicine Practice and Research Network (EMED PRN) for: Rech MA, Brown C, Slocum GW, et al. Impact of desmopressin on hematoma expansion in patients presenting to the emergency department on antiplatelet therapy. Am J Emerg Med. 2025;93:126-131. https://doi.org/10.1016/j.ajem.2025.03.052
• Sarah Wright: October 2025 Door-to-Needle Time Champion, Baptist Health North Little Rock Stroke Committee for a facility record 4-minute door-to-needle time.

Grants

• Megan Rech:
  • 2026-2029 Health Sciences Research Merit Award, Department of Veterans Affairs.
  • 2025-2027 Evaluation of Infections Linked to Contaminated Water Exposure at Camp Lejeune Evidence to Policy Evaluation Center for Veterans: EPEC-Vet, Department of Veterans Affairs.
  • 2025-2026 Characterizing Prescribing Practices in the Veterans Health Administration’s Tele-Emergency Medicine Program VA Emergency Medicine Analytics Team (EMAT) and the VA Office of Rural Health, Department of Veterans Affairs.

Publications

• Cendagorta A, Lattuca F, Moore J, O’Dwyer K, Baran A, Acquisto NM, et al. Evaluation of clotting and bleeding risk associated with the use of asparaginase drugs in patients with acute lymphoblastic leukemia. J Hematol Oncol Pharm. 2026;16:1-9.
• Dash S, Acquisto NM, McElliott J, et al. Effect of a best practice advisory activated “kit in hand” naloxone distribution program in the emergency department. Am J Emerg Med. 2025;88:134-139. https://doi.org/10.1016/j.ajem.2024.11.065
• Hintze TD, Downing JV, Acquisto NM, et al. Metoprolol vs diltiazem for atrial fibrillation with rapid ventricular rate: systematic review and meta-analysis of adverse events. Am J Emerg Med. 2025;89:230-240. https://doi.org/10.1016/j.ajem.2024.12.070
• Kaucher K, Acquisto NM, Lowrey K, Gilliam E, Buchanan J, Metz M. Improvement in HIV screening follow-up rates with emergency department pharmacist dispensing and counseling of post-exposure prophylaxis. JAPhA Pract Innov. 2025;2(1):100025. https://doi.org/10.1016/j.japhpi.2024.100025
• Kumar S, Jones CMC, Acquisto NM, et al. Snake envenomations reported to poison centers in New York State, 2011-2022; 12 years of data. Wilderness Environ Med. 2025 Oct 29. https://doi.org/10.1177/10806032251386818
• Miglani A, Chamberlin S, Acquisto NM, et al. Human factors in trauma resuscitation (people, environment, communication & professionalism): a narrative review. Curr Trauma Rep. 2026;12:3. https://doi.org/10.1007/s40719-025-00300-7
• Nacca N, Acquisto NM, Schailey C, Lambrych MC, Mazzillo JA. Increasing naloxone distribution to opioid overdose patients in the emergency department following best practice alert enhancement. Am J Emerg Med. 2026 Feb 8. [Epub ahead of print]. https://doi.org/10.1016/j.ajem.2026.01.056
• O’Connor M, Acquisto NM. Research pearl: scientific research and advancements are occurring at a rapid pace, but does the way research results are disseminated need a change? Society of Critical Care Medicine-Clinical Pharmacy and Pharmacology Section Newsletter. 2025;25(4):18-19.
• Pero-Cleveland E, Rabey J, Mosher AJ, Geraci E, DePaul S, Hutchinson D, Natoli JL, van der Jagt E, Acquisto NM. Benefit of an interdisciplinary pediatric sedation team with a clinical pharmacist on outpatient appointment duration and procedural sedation time. Pediatr Anesth. 2026;36(1):81-87. https://doi.org/10.1111/pan.70069
• Polito NB, Fellows SE, Knapp AS, Acquisto NM. Evaluation of neuromuscular blocking agent use in myasthenia gravis patients undergoing rapid sequence intubation. Am J Emerg Med. 2026;103:21-25. https://doi.org/10.1016/j.ajem.2026.01.019
• Shah M, Fargo E, Acquisto NM, Miglani A. Large academic enterprise load balancing: ED patient transfers to regional hospitals. Am J Emerg Med. 2026;102:213-215. https://doi.org/10.1016/j.ajem.2026.01.015
• Treu CN, Stilwell AM, Cheon E, Acquisto NM. Use of lipoglycopeptides for moderate to severe ABSSSI in the emergency department. Am J Emerg Med. 2025;87:44-50. https://doi.org/10.1016/j.ajem.2024.10.040
• Valentino M, Acquisto NM, Torchon R, et al. Process implementation and outcomes associated with patient-controlled analgesia in the emergency department for adult sickle cell patients. Am J Emerg Med. 2026;99:256-263. https://doi.org/10.1016/j.ajem.2025.10.001
• Booth D, Tempo A. Improving disaster preparedness and reaction in a community medical center pharmacy through gamification. Pharmacy practice in focus: health systems. Pharmacy Times. 2025;14(6):14-18.
• Brown C, Engstrom K, Gilbert B, Faine B, Mattson A, Cole K, Bellolio F, Acquisto NM, Wieruszewski E, Mercer K, Gerberi D, Rabinstein A, Rech MA. Evaluation of emergency medicine pharmacist participation in time to oral anticoagulation reversal: a systematic review and meta-analysis. J Am Coll Clin Pharm. 2025;9(2):e70156. https://doi.org/10.1002/jac5.70156
• Dewitt K, Acquisto NM. Shaping the future: tracking the evolution and growth of PGY2 emergency medicine pharmacy residency programs. Am J Health Syst Pharm. 2025;82(24):1432-1436. https://doi.org/10.1093/ajhp/zxaf203
• Huhtelin DP, Mercer KJ, Nasrazadani Z, Arsenault V, Al-Saiegh S, Gilbert BW. Building a better community: emergency medicine pharmacy practice in the community hospital setting. Am J Health Syst Pharm. 2025;82(24):1403-1410. https://doi.org/10.1093/ajhp/zxaf199
• Joachim AC, Mercer KJ, Gutierrez MA, Waxler CM, Aradhya SN. Diltiazem vs metoprolol for atrial fibrillation with rapid ventricular response in heart failure with reduced ejection fraction in emergency departments. Front Emerg Med. 2025 Oct 21. [Epub ahead of print]. https://doi.org/10.18502/fem.v9i3.20017
• Mercer KJ, Gilbert BW, Robertson A, Blue H, Kroll CE, Bellolio F. The missing piece in The Pitt: a call for emergency medicine pharmacist representation. Am J Emerg Med. 2025;96:291-292. https://doi.org/10.1016/j.ajem.2025.08.037
• Mercer KJ, Howington G, Brown CS, Gilbert B, Cole K, Acquisto NM, Zimmerman D, Ray L, Gerberi D, Mattson AE, Coralic Z, Faine B, Rech MA; on behalf of EMPHARM-NET Collaborators. Assessing the impact of emergency medicine pharmacists on fibrinolytic door-to-needle fibrinolytic times in acute ischemic stroke: a systematic review and meta-analysis (Pharmacist-assisted Stroke Treatments I ((PhAST-1)). Am J Emerg Med. 2025;98:57-64. https://doi.org/10.1016/j.ajem.2025.08.014
• Forehand CC, Benken ST, Madorsky M, Mohamed A, Nguyễn JV, Dixit D, et al. Pharmacotherapeutic controversies during temperature control after out-of-hospital cardiac arrest: a semi-structured literature review. Pharmacotherapy. 2026;46(1):e70095. https://doi.org/10.1002/phar.70095
• Rech MA, Faine B. Pharmacists on the frontlines: advances in emergency medicine pharmacy practice. Am J Health Syst Pharm. 2025;82(24):1310-1311. https://doi.org/10.1093/ajhp/zxaf241
• Rech MA, Gottlieb M. Naloxone should be routinely used for undifferentiated out-of-hospital cardiac arrest. Ann Emerg Med. 2025;86(6):685-686. https://doi.org/10.1016/j.annemergmed.2025.03.013
• Rech MA, Gottlieb M. Calcium channel blockers should be preferentially used to treat atrial fibrillation with rapid ventricular response. Ann Emerg Med. 2026;87(1):79-81. https://doi.org/10.1016/j.annemergmed.2025.05.012
• Rech MA, Shalaby M, Gage KA, Gottlieb M. Managing cannabinoid hyperemesis syndrome. Ann Emerg Med. 2026 Feb 2. [Epub ahead of print]. https://doi.org/10.1016/j.annemergmed.2025.12.024
• Dager WE, Rech MA, Gilbert BW. Reversing anticoagulants: influence of anticoagulation stewardship and key considerations for optimizing outcomes. Ann Pharmacother. 2026;60(2):196-201. https://doi.org/10.1177/10600280251356019
• Gottlieb M, Shalaby M, Rech MA. The challenge of cannabinoid hyperemesis syndrome in the emergency department. JAMA Netw Open. 2025;8(11):e2545316. https://doi.org/10.1001/jamanetworkopen.2025.45316
• Gurnani PK, Smetana KS, Dillis J, Flannery AH, Peppard WJ, Van Berkel Patel MA, Rech MA. PHarmacist Caring for CRITically Ill and EMergency Medicine Patients and Big Five personality traits: PHARM-CRIT and EM BIG 5. Am J Health Syst Pharm. 2025 Dec 26. [Epub ahead of print]. https://doi.org/10.1093/ajhp/zxaf364
• Htet NN, Walker JA, Jafari D, Rech MA, et al. Outcomes of boarding critically ill patients in U.S. EDs: a systematic review and meta-analysis. Am J Emerg Med. 2025;99:339-347. https://doi.org/10.1016/j.ajem.2025.10.036
• Long B, Rech MA, Gottlieb M. Managing angioedema. Ann Emerg Med. 2026;87(2):219-228. https://doi.org/10.1016/j.annemergmed.2025.07.002
• Markovic N, Budde E, Evans CT, Finch D, Xia Y, Huo Z, Han JH, Rech MA. Time to hemostatic agent administration increases mortality in veterans with factor Xa inhibitor-related intracranial hemorrhage. Am J Emerg Med. 2025;98:201-206. https://doi.org/10.1016/j.ajem.2025.08.047
• Sharabun M, O’Connell R, Greller H, Smith AP. Oral ibuprofen versus intramuscular ketorolac for acute musculoskeletal back pain in the emergency department: a prospective analysis. J Pharm Pract. 2025 Nov 6. [Epub ahead of print]. https://doi.org/10.1177/08971900251394098
• Weant KA. Pharmacotherapy management of beta-blocker toxicity in the emergency department. Adv Emerg Nurs J. 2026;48(1):6-10. https://doi.org/10.1097/TME.0000000000000603
• Weant KA, Acquisto NM, Brown M, Iuppa J, Rappaport S, Weeda E. Developing a pharmacy residency research program educational series: a review of the literature and considerations for implementation. Am J Health Syst Pharm. 2025;82(13):e641-e647. https://doi.org/10.1093/ajhp/zxae382
• Weant KA, Gregory H. Turn data into action: how to negotiate evidence-based decision-making in the emergency department. Am J Health Syst Pharm. 2025;82(24):1426-1431. https://doi.org/10.1093/ajhp/zxaf139
• Weant KA, Gregory H. Pharmacotherapy management of acute migraine in the emergency department. Adv Emerg Nurs J. 2025;47(4):269-281. https://doi.org/10.1097/TME.0000000000000588
• DiDomenico RJ, Smith SE, Chan A, Dougherty Z, Griebe K, Lee YR, Murray B, Roberts RJ, Shin ET, Vonderhaar JM, Weant KA. A roadmap for studying the impact of pharmacist board certification on patient outcomes: feasibility, applicability, and methodological considerations. J Am Coll Clin Pharm. 2026;9(2):e70165. https://doi.org/10.1002/jac5.70165
• Wright SS, Wright C. The importance of medication reconciliation in a patient with Parkinson’s disease. Sr Care Pharm. 2025;40(11):443-449. https://doi.org/10.4140/TCP.n.2025.443
• Zimmerman DE, Rech MA, Covvey JR, Acquisto NM, Slocum GW, Howington GT, Woolum JA, Flack T, Ray L, Porter B, Kum V, VanWert E, Faine BA. Hepatitis B vaccination and immune globulin administration in patients presenting to the emergency department following sexual assault. Am J Emerg Med. 2025;97:188-192. https://doi.org/10.1016/j.ajem.2025.07.060

Presentations

• Deborah Booth:
  • Implementation of targeted medication warnings for hyperkalemia. Presented at: Atlantic Health Research Day; October 2025; Morristown, NJ.
  • Implementation of targeted medication warnings for hyperkalemia. Presented at: FDB EPIC User Meeting; September 2025; Atlanta, GA.
• Kevin Mercer: Cardiac arrest & cactus juice: a Texan’s guide to poisoning resuscitation. Presented at: Texas Society of Health-System Pharmacists Specialty Practice Seminar; September 2025; San Antonio, TX.
• Elise Metts, Kevin Mercer, Jamie Sterr: From vial to vein: the pharmacist’s role in medication administration. Presented at: Society for Academic Emergency Medicine Academy of Emergency Medicine Pharmacists National Webinar; October 2025; virtual.
• Sarah Wright: The state of emergency medicine pharmacy in Arkansas 2025: where we’ve been, where we are, and where we’re going. Presented at: Arkansas Association of Health-System Pharmacists Fall Seminar; October 2025; Little Rock, AR.

New ACCP Fellows

• Caitlin S. Brown
• Brian W. Gilbert
• David E. Zimmerman

Other Notable Achievements

• Kaely Miller: ACCP National Resident Advisory Committee Chair.
• Areeb Nagamiyan: BCEMP.
• Jerika Nguyễn-Klatt:
  • ACCP Public and Professional Relations Committee.
  • ACCP Health Equity PRN Chair-Elect.
  • Society of Critical Care Medicine (SCCM) Michigan Chapter Education Committee Chair.
• Megan Rech:
  • Society for Academic Emergency Medicine (SAEM) Academy of Emergency Medicine Pharmacists (AEMP) Inaugural President.
  • Society of Critical Care Medicine (SCCM) Clinical Pharmacy & Pharmacology (CPP) Section Immediate Past Chair.
• Myroslava Sharabun:
  • BCEMP.
  • New York State Council of Health-System Pharmacists Westchester County Society of Health-System Pharmacists President-Elect.
• Natalie Slusarenko: BCEMP.

• Sarah Wright: Arkansas Association of Health-System Pharmacists Membership & Communications Council Chair.

Endocrine and Metabolism PRN

 Promotions

• Nicole Albanese: Clinical Professor, University at Buffalo School of Pharmacy and Pharmaceutical Sciences.
• Rick Barbarash: National Field Director, US Metabolic Bone. Medical Science Liaison, Ultragenyx Pharmaceutical Inc.
• Emily Shin: Pharmacy Supervisor for the Clinical Embedded Pharmacy Team, University of Nebraska Medical Center.

 Publications

• Stachnik B, Belen A, Cunningham L, Juco K, Mathew S, Ali A. Sat-36. Transition to tirzepatide after development of non-arteritic anterior ischemic optic neuropathy during semaglutide treatment. J Am Coll Clin Pharm. 2025;8(12):1465-1466. https://doi.org/10.1002/jac5.70148
• Donihi AC. Inpatient diabetes and hyperglycemia. In: Sanoski CA, Witt DM, eds. Pharmacotherapy Self-Assessment Program, 2026 Book 1. Endocrinology and Nephrology. American College of Clinical Pharmacy; 2026:51-68.
• Finn A, Cunningham L, Mathew S, Juco K, Belen A. Sat-37. Delayed localized drug rash to tirzepatide with safe use of other incretin-based therapies in type 2 diabetes. J Am Coll Clin Pharm. 2025;8(12):1465. https://doi.org/10.1002/jac5.70148
• Isaacs D, Adelman M. Continuous glucose monitoring. In: Sanoski CA, Witt DM, eds. Pharmacotherapy Self-Assessment Program, 2026 Book 1. Endocrinology and Nephrology. American College of Clinical Pharmacy; 2026:69-74.
• Isaacs D, Adelman M. Insulin pumps. In: Sanoski CA, Witt DM, eds. Pharmacotherapy Self-Assessment Program, 2026 Book 1. Endocrinology and Nephrology. American College of Clinical Pharmacy; 2026:75-80.
• Lennon A. Epidemiology and pathophysiology of diabetes and obesity. In: The Pharmacist’s Pocket Guide for Diabetes and Obesity. Springer; 2025:chap 1.
• Lennon A. Overweight and obesity. In: Sanoski CA, Witt DM, eds. Pharmacotherapy Self-Assessment Program, 2026 Book 1. Endocrinology and Nephrology. American College of Clinical Pharmacy; 2026:21-50.
• Lingow S, Carris N, Clements C, Courtney L, Lennon A, Sherrill C, Van Dril E. The pharmacist’s role in the use of incretin-based therapies for weight management: an opinion of the Endocrine and Metabolism Practice and Research Network of the American College of Clinical Pharmacy. J Am Coll Clin Pharm. 2025;8(10):1078-1093. https://doi.org/10.1002/jac5.70111
• Yogaratnam D, Mukherjee SM, Getchell K, Dima L. Omalizumab: first approved anti-IgE therapy for multiple food allergies. Am J Ther. 2026;33(1):e39-e45. https://doi.org/10.1097/MJT.0000000000002078
• Rowe JM. Adult hormone replacement therapy. In: Sanoski CA, Witt DM, eds. Pharmacotherapy Self-Assessment Program, 2026 Book 1. Endocrinology and Nephrology. American College of Clinical Pharmacy; 2026:151-177.
• Salama L, St. Peter WL. Estimates of kidney function. In: Sanoski CA, Witt DM, eds. Pharmacotherapy Self-Assessment Program, 2026 Book 1. Endocrinology and Nephrology. American College of Clinical Pharmacy; 2026:81-102.
• Schumacher C. Cardiovascular-kidney-metabolic (CKM) syndrome. In: Sanoski CA, Witt DM, eds. Pharmacotherapy Self-Assessment Program, 2026 Book 1. Endocrinology and Nephrology. American College of Clinical Pharmacy; 2026:1-20.

Presentations

• Hannah Ayers, Karla Crespo Morales, John Shilka, Liz Van Dril. Dapagliflozin-induced acute pancreatitis in heart failure reduced ejection fraction: a case report and review of the literature. Poster presented at: 2025 ACCP Annual Meeting; October 2025; Minneapolis, MN.
• Lauren Cunningham. Women’s Health Focus Session—Bridging gender gaps in care: advancing equity in cardiovascular disease management—navigating the pooled cohort equations (PCE) and predicting risk of cardiovascular disease events (PREVENT) equations for equitable cardiovascular disease management. Presented at: 2025 ACCP Annual Meeting; October 2025; Minneapolis, MN.
• Akrum Elshazali, Elma Abdulbaki, John Shilka, Liz Van Dril. Urate-lowering therapy selection in an HLA-B*5801 positive patient with a history of cardiovascular disease and allopurinol-treated gout: a case report. Poster presented at: 2025 ACCP Annual Meeting; October 2025; Minneapolis, MN.
• Abby Lennon, Lindsay Courtney. Weighting on the world to change: updates on the management of overweight and obesity. Presented at: 2025 ACCP Annual Meeting; October 2025; Minneapolis, MN.
• Christie Schumacher:
  • Beyond glycemic management: evolving therapies for type 2 diabetes and cardiometabolic kidney care. Presented at: Association of Diabetes Care and Education Specialists Michigan Coordinating Body Annual Meeting; October 2025; Lansing, MI.
  • Syncing data and care: using continuous glucose monitoring to improve cardiometabolic kidney care. Presented at: Carle Health Regional Seminar on Diabetes Management; October 2025; Urbana, IL.
  • The next step in medication reconciliation: integrating comprehensive medication management strategies at care transitions: creating a role for comprehensive medication management in transitions of care. Presented at: 2025 ACCP Annual Meeting; October 2025; Minneapolis, MN.
• Christie Schumacher, Liz Van Dril. Laying the foundation: practical guidance for starting and developing ambulatory care pharmacy services. Presented at: Illinois Council of Health-System Pharmacists Annual Meeting; September 2025; Oakbrook Terrace, IL.
• Liz Van Dril:
  • Diabetes management. Presented at: 2026 Commissioned Training on Ambulatory Care Management for Cardiovascular Diseases for Pharmacists Programme; January 2026; virtual (Hong Kong).
  • TEAM CGM: team support to improve glycemic control using CGM in diverse populations: a pilot study. Presented at: American Public Health Association 2025 Annual Meeting & Expo Poster Session; November 2025; Washington, DC.

New ACCP Fellows

• Andrew S. Bzowyckyj
• Dustin Carneal
• Christina H. Sherrill

Other Notable Achievements

• Lauren Cunningham: Appointed as Associate Editor of Canadian Journal of Physiology and Pharmacology.
• Lauren Cunningham and Liz Van Dril:
  • Interviewees on a podcast “Beyond the scale: the Ozempic effect.” Drugwatch. 2025 June 19.
  • Interviews for an article “Can you take Ozempic if you have a thyroid problem?” The CheckUp by Single Care. 2025 June 30.
• Christie Schumacher: Selected as a member of the American Diabetes Association (ADA) Professional Practice Committee responsible for writing the 2027 ADA Standards of Care.
• Alissa Segal: Appointed as Inaugural Editor-in-Chief, American Diabetes Association’s new journal: Diabetes, Obesity, and Cardiometabolic CARE.
• Liz Van Dril: Appointed as Faculty Panel Chair, 2026 Endocrinology and Nephrology Pharmacotherapy Self-Assessment Program.

Geriatrics PRN

Grants

• Sum Lam: Community Engaged Learning (CEL) Grant 2025-2026. St John’s University. Principal Investigator.
• Emily Peron: Quantifying Parkinson’s Disease Burden in Virginia: A Population-Based Study of Spatial and Demographic Inequities. Virginia Commonwealth University Parkinson’s and Movement Disorders Center Pilot Grants Program. Co-Investigator ($75,000).

Publications

• Peron EP, Donohoe KL, Cary A, Dao E, Johnston R, Syed R, Atkinson J, Gates A, Johnson M, Nixon-Lambert E, Reilly S, Sifa I, Price ET, Crouse E, Sargent L, Zimmerman KM, et al. Assessing the feasibility of the Minnesota medication self-management toolkit 4-step approach in low-income community-dwelling older adults. Sr Care Pharm. 2025;40(11):472-480. https://doi.org/10.4140/TCP.n.2025.472
• Geerken K, Peron EP, Marrs S, Slattum PW. Ageism in health care. In: Gendron T, ed. Disrupting Ageism: From Theory to Practice. Elsevier; 2025.
• Safarpour D, Brooks A, Smiley A, Katzka A, Shprecher DR, Greene JG, Pahwa R, Troche MS, Kriegel Z, Peron EP, et al. Consensus expert recommendations for management of dysphagia during hospital admission in Parkinson’s disease. J Parkinsons Dis. 2026;16(1):16-35. https://doi.org/10.1177/1877718X251410503
• Posey LM. Health and wealth in the era of longevity. Gerontological Society of America; 2025. [Epub ahead of print]
• Ager E, Jones A, Lewis A, Nnadi C, Trinh K, Price E, Crouse E, Sargent L, Regal R, Zimmerman KM, Slattum PW, Donohoe KL, Peron EP. Health conditions and medications associated with falls in low-income community-dwelling older adults. Sr Care Pharm. 2025;40(10):424-430. https://doi.org/10.4140/TCP.n.2025.424

Presentations

• Krista Donohoe, Emily Peron:
  • Age-friendly health system’s 4M integration in community-based care to improve medication adherence for low-income older adults. Presented at: American Society of Health-System Pharmacists Midyear Clinical Meeting; December 2025; Las Vegas, NV.
  • Prevalence of neurodivergent conditions in a school of pharmacy. Presented at: American Society of Health-System Pharmacists Midyear Clinical Meeting; December 2025; Las Vegas, NV.
• Krista Donohoe, Emily Peron, Kristin Zimmerman: Student-led focus groups to assess the feasibility of the Minnesota effective medication self-management toolkit 4-step approach in low-income community-dwelling older adults. Presented at: American Society of Health-System Pharmacists Midyear Clinical Meeting; December 2025; Las Vegas, NV.
• Joshua Pappachen, Shiv Patel, Sum Lam: Evaluation of confidence level in foundational principles of aging among pharmacy students. Presented at: ACCP Annual Meeting Poster Session; October 20, 2025; Minneapolis, MN.
• Emily Peron: Community-engaged research and workforce education in mobile health: tips for successful replication. Presented at: Gerontological Society of America Annual Scientific Meeting; November 12, 2025; Boston, MA.

GI/Liver/Nutrition PRN

Publications

• Pham TQ, Bass SN, Yerke JR. Terlipressin administration strategies in hepatorenal syndrome-acute kidney injury: a narrative review of continuous infusion and intermittent bolus approaches. Pharmacotherapy. 2025;45(12):852-861. https://doi.org/10.1002/phar.70084
• Mulherin DM, Cogle SV. Enteral nutrition. In: Haines ST, Nolin TD, Ellingrod VL, et al, eds. DiPiro’s Pharmacotherapy: A Pathophysiologic Approach. 13th ed. 2026.
• Todor LA, Boyd AN, Reger MR, Patel A, Ansari N, Tran N, Faris J, Quan AN, Kramer CJ, Walroth TA, Kuhrau SK, Mueller SW, Adams B, Pham F, Alexander KM, Smith KE, Maynard KM, DeWitt A, Smith L, Stevkovic-Raseta N, Moreno NM, Cogle SV, et al. An appraisal of pharmacotherapy-pertinent literature published in 2023 and 2024 for clinicians caring for patients with thermal or inhalation injury. J Burn Care Res. 2025 Oct 21. [Epub ahead of print]. https://doi.org/10.1093/jbcr/iraf201
• Rudoni MA. Stress ulcer prophylaxis in septic shock: interpreting new evidence in a persistent clinical debate. Crit Care Med. 2026;54(3):670-672. https://doi.org/10.1097/CCM.0000000000007048
• Alexander KM, Damania R, Rudoni MA. AI in critical care training: balancing ethics and effectiveness. SCCM Crit Connect. Summer 2025;24(3):14-15.
• Conroy GM, Yerke JR, Rudoni MA, Kapoor A, Bass SN. Hemodynamic impact of dexmedetomidine in critically ill patients with and without cirrhosis: a retrospective cohort study. J Crit Care. 2026 Jan 12. [Epub ahead of print]. https://doi.org/10.1016/j.jcrc.2026.155424

 Presentations

• Cogle SV:
  • Infusing safety: strategies for improving the PN use process. In: Closing the Gaps in Parenteral Nutrition Safety: Results and Implications of the 2025 ASPEN PN Use Survey. Presented at: ASPEN Nutrition Science and Practice Conference; February 2026; Long Beach, CA.
  • Feeling salty? A primer on salt-based dosing of electrolytes in parenteral nutrition roundtable. Presented at: ASPEN Nutrition Science and Practice Conference; February 2026; Long Beach, CA.
  • Mixing it up: parenteral nutrition formulations, compatibility, and compounding. In: Basic Skills in Parenteral Nutrition Management Skills Lab. Presented at: ASPEN Nutrition Science and Practice Conference; February 2026; Long Beach, CA.

Health Equity PRN

 Awards

• Sally Arif: Faculty Advisor of the Year, Midwestern University Student Senate.
• Jerika V. Nguyễn-Klatt: Service Excellence Award, ACCP Health Equity PRN.

 Publications

• Arif S. Shift: A Practical Guide to Cultivating Equity and Inclusion in Healthcare Education. Equity-Minded Collective; 2025.
• Devraj R, Covvey J, Arif S. Bridging the digital divide: the importance of techquity in pharmacy education. Am J Pharm Educ. 2025;89(4):101380. https://doi.org/10.1016/j.ajpe.2025.101380
• Simeon M, Evans E, Arif S, Granado T, Okwuosa T, Volgman A. Chemotherapy-induced Takotsubo cardiomyopathy: a systematic review of mechanisms, drug associations, and clinical implications. Am Heart J Plus. 2026;63:100723. https://doi.org/10.1016/j.ahjo.2026.100723
• Horace AE, Below J, Brown A, Hill S. Equipping the front lines: building a harm reduction program for Louisiana first responders. J Am Pharm Assoc. 2026;66(1):102945. https://doi.org/10.1016/j.japh.2025.102945
• Johnson ST, Cook K, Dallmeier J, Heuett N, Barker K. Hospital price transparency: a primer. Am J Health Syst Pharm. 2026 Jan 23. [Epub ahead of print]. https://doi.org/10.1093/ajhp/zxag022
• Forehand CC, Benken ST, Madorsky M, Mohamed A, Nguyễn-Klatt JV, et al. Pharmacotherapeutic controversies during temperature control after out-of-hospital cardiac arrest: a semi-structured literature review. Pharmacotherapy. 2026:46(1):e70095. https://doi.org/10.1002/phar.70095

 Presentations

• Sally Arif:
  • Future-focused dialogue: from inspiration to action. Presented at: Winter 2026 FIP Women in Science and Education (FIPWiSE) Summit; February 2026; virtual.
  • Whole person care is better care: a drive towards pharmacoequity. Presented at: 2025 ACCP Annual Meeting; October 2025; Minneapolis, MN.
  • Bridging gender gaps in care: advancing equity in cardiovascular disease management. Presented at: 2025 ACCP Annual Meeting; October 2025; Minneapolis, MN.
  • From awareness to action: promoting pharmacoequity in chronic disease state management. Presented at: Fall 2025 Illinois Council of Health-System Pharmacists (ICHP) Annual Meeting; September 19, 2025; Oak Brook, IL.
  • Culturally competent care-health literacy is a human right. Presented at: Fall 2025 International Federation of Pharmacist (FIP) World Congress Meeting PharmClarity: Advancing Health Literacy in Pharmacy Care Summit; August 30, 2025; Copenhagen, Denmark.
• Alexis Horace: HIV PREP & PEP for pharmacist. Presented at: SCATC Workshop; January 30, 2026; New Orleans, LA.
• Steven Johnson: Hospital price transparency—payer/provider perspectives and the various shades of gray. Presented at: AMCP Nexus Meeting; October 27-30, 2025; National Harbor, MD.
• Jerika V. Nguyễn-Klatt: Alarm management strategies. Presented at: American Association of Critical Care Nursing Greater Cincinnati Chapter; December 10, 2025; Cincinnati, OH.

Other Notable Achievements

• Jerika V. Nguyễn-Klatt:
  • Chair-Elect, ACCP Health Equity PRN.
  • Chair, Education Committee, SCCM Michigan Chapter.
  • ACCP Public and Professional Relations Committee.

Health Outcomes PRN

Publications

• Billups SJ, Daffron A, Harty C, Lowe RN, Lobo I. Centralized outreach with embedded pharmacist e-consultation to reduce therapeutic inertia and improve blood pressure control. Am J Health Syst Pharm. 2025;82(22):1249-1255. https://10.1093/ajhp/zxaf096
• Billups SJ, Fraumeni BR, Schilling LM, et al. Improving access to rheumatology care: evaluation of a rheumatology electronic consultation program. Arthritis Care Res (Hoboken). 2025 Nov 28. [Epub ahead of print]. https://doi.org/10.1002/acr.70003
• Claus LW, Auten ME, Saseen JJ, Billups SJ. Guideline adherence of xanthine oxidase inhibitor utilization to treat gout in primary care. J Manag Care Spec Pharm. 2025;31(9):922-927. https://doi.org/10.18553/jmcp.2025.31.9.922
• Keime N, Titus O, Ziogaite M, Hugh J, Schilling L, Dellavalle R, Billups SJ. Primary care physicians prescribe fewer expensive combination medications than dermatologists for acne: a retrospective review. J Manag Care Spec Pharm. 2025;31(12):1237-1243. https://doi.org/10.18553/jmcp.2025.31.12.1237
• Lobo I, Koon K, Potthast K, Ozmina K, Billups SJ. A multi-intervention approach to blood pressure control: a description of how a large university based primary care clinic tackled hypertension. Popul Health Manag. 2026;29(1):18-26. https://doi.org/10.1177/19427891251393941
• Worledge EA, Billups SJ, Titus OJ, Saseen JJ. Achievement of low-density lipoprotein cholesterol thresholds in very high-risk atherosclerotic cardiovascular disease. J Clin Lipidol. 2025;19(4):860-868. https://doi.org/10.1016/j.jacl.2025.04.186
• Alpert JM, Kovach JD, Casacchia NJ, et al. Hospitalization experiences among nursing home residents with dementia. J Am Med Dir Assoc. 2026;27(2):106022. https://doi.org/10.1016/j.jamda.2025.106022
• Gasoyan H, Alavi MH, Zajichek A, Casacchia NJ, et al. Macrovascular and microvascular outcomes of metabolic surgery versus GLP-1 receptor agonists in patients with diabetes and obesity. Nat Med. 2025;31(10):3341-3349. https://doi.org/10.1038/s41591-025-03893-3
• Gasoyan H, Butsch WS, Casacchia NJ, et al. Reasons for discontinuation of obesity pharmacotherapy with semaglutide or tirzepatide in clinical practice. Obesity (Silver Spring). 2025;33(12):2296-2303. https://doi.org/10.1002/oby.70058
• Liu L, McKnight ER, Bonny AE, Lemelin K, Cai Y, Nahata MC. Patterns of psychotropic medication use, medication switching, augmentation, and non-persistence in adolescents and young adults with co-occurring psychiatric morbidities and opioid use disorder. BMC Psychiatry. 2026 Feb 20. [Epub ahead of print]. https://doi.org/10.1186/s12888-026-07916-2
• Liu L, Wang K, Neidecker MV, Yang H, Nahata MC. Cost-effectiveness of first-line regimens for Helicobacter pylori infection in the United States. Am J Gastroenterol. 2026 Jan 21. [Epub ahead of print]. https://doi.org/10.14309/ajg.0000000000003924
• Xu H, Zhao H, Tao H, Liu L. Awareness, attitudes, and clinical utilization of vonoprazan for Helicobacter pylori infection and gastroesophageal reflux disease among Chinese physicians: a nationwide cross-sectional study. BMC Gastroenterol. 2025;25(1):795. https://doi.org/10.1186/s12876-025-04408-7
• Zou Y, Xiong G, Liu L. Patterns of weight loss attempts and clinically significant weight loss among US adolescents and adults: analysis of NHANES 2021-2023. Prev Med Rep. 2026;61:103375. https://doi.org/10.1016/j.pmedr.2026.103375

 Presentations

• Sarah J. Billups:
  • Applying a clinical lens to medication adherence quality measures—do they measure up? Presented at: American Society of Health-System Pharmacists Midyear Clinical Meeting; December 7, 2025; Las Vegas, NV.
  • Health outcomes: designing and implementing collaborations between clinical pharmacists and physicians. Presented at: 2025 ACCP Annual Meeting; October 18, 2025; Minneapolis, MN.
  • Getting payment for pharmacist services through a medical billing partnership with a physician practice. Presented at: Align Conference; September 25, 2025; Minneapolis, MN.
  • Making patients healthier one millimeter of mercury at a time. Presented at: Tennessee Heart Health Learning Collaborative Webinar; July 29, 2025; virtual.

Other Notable Achievements

• Sarah J. Billups: Fellow, American College of Chest Physicians.

Infectious Diseases PRN

 Promotions

• Wasim El Nekidy: Clinical Professor of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH.

 Awards

• Madison L. Adams: PGY1 Residency Preceptor of the Year, Northern Navajo Medical Center, Indian Health Service.
• Valerie Buckley: 2025 New Pharmacist Award, Texas Society of Health-System Pharmacists (TSHP).

 Publications

• Aisha A, Al Sulaiman K, Damfu N, Alowais SA, Alotaibi S, Alsowaida YS, Aljohani MA, Bifari N, Alshammari F, Asiri M, Almasoudi IA, Almuzaini M, Alqurashi AF, Alobathani SK, Almodyan EJ, et al. Effectiveness and safety of caspofungin for the treatment of candidemia in critically ill patients with obesity: a multicenter retrospective cohort study. Med Mycol. 2025;63(10):myaf093. https://doi.org/10.1093/mmy/myaf093
• Alqadi A, Almodyan E, Alanazi MN, et al. Vitamin D supplements and effect on glycemic control and lipid profile in individuals living with diabetes: a retrospective study. Eur Rev Med Pharmacol Sci. 2025;29(5):248-257. https://doi.org/10.26355/eurrev_202505_37223
• Spellberg B, Wald-Dickler N, Holtom P, Meyer-Sautter P, Camp A, Diaz AD, Buhamad R, Vazquez ASM, Aguirre-Garcia GM, Stanton M, Butler-Wu SM, Chiu I, Ergenc Z, Bhoojhawon G, Murri R, Maraolo AE, Cabanilla G, Riccardi N, Tshisevhe V, Behenna C, Williams KS, Kufel WD, et al. Reply to Datta, “Is static or cidal antibiotic falsifiable?” Antimicrob Agents Chemother. 2025;69(11):e0139125. https://doi.org/10.1128/aac.01391-25
• Chiasson J, Sawadogo J, Kent M. Education and electronic health record implementation-better together? An assessment of compliance of oral vancomycin dosing for Clostridioides difficile infection and the impact of different antimicrobial stewardship interventions. Antimicrob Steward Healthc Epidemiol. 2026;6(1):e21. https://doi.org/doi:10.1017/ash.2025.10272
• Covington EW, Chae JL, Gunter SG. A retrospective within-subjects analysis of vancomycin Bayesian modeling with pre-steady-state vs steady-state concentrations. J Pharm Technol. 2025;41(6):268-275. https://doi.org/10.1177/87551225251362731
• Covington EW, Grabowsky A, Moore M, Reagan AT, Lee L, Cody R. Effect of pharmacist involvement in emergency department microbiological culture follow-up services on clinical outcomes and workflow: a systematic review. J Am Coll Clin Pharm. 2025;8(10):1046-1060. https://doi.org/10.1002/jac5.70106
• Kuska ES, Mlyniec J, Wantuch KL, Brock L, DeSear KE, Gauthier TP, Hirsch EB, Kufel WD, Morrisette T, Pearsall M, White BP, et al. A full educational resource review of grey literature resources for vancomycin dosing tutorials. JAC Antimicrob Resist. 2026;8(1):dlaf248. https://doi.org/10.1093/jacamr/dlaf248
• Ghazi IM, Omar AF, El Nekidy WS, Harb G, Alrahmany D. Innate immune response to bacterial infections in hospitalized glucose-6-phosphate dehydrogenase-deficient patients; diagnostic value of white blood cell count. Clin Immunol. 2026;282:110613. https://doi.org/10.1016/j.clim.2025.110613
• Wallace JL, Rungkitwattanakul D, Khan RW, Anderson L, Anderson ER, El Nekidy WS, et al. Adopting race-free estimated glomerular filtration rate for unifying medication-related decision-making: an opinion of the Nephrology Practice and Research Network of the American College of Clinical Pharmacy. J Am Coll Clin Pharm. 2026;9(2):e70153. https://doi.org/10.1002/jac5.70153
• Poux N, Gillett E, Franklin C, Estano M, Stevenson HS, Dewan C, Dionne B, Kubiak DW, Pearson JC, et al. Evaluation of the safety of cefazolin monotherapy in outpatient parenteral antimicrobial therapy at a large academic medical center. Open Forum Infect Dis. 2025;12(10):ofaf592. https://doi.org/10.1093/ofid/ofaf592
• Nemecek BD, St. Peter WL, Hong LT, Anderson ER, El Nekidy WS. Current practices in estimating kidney function: insights from a cross-sectional survey. J Am Coll Clin Pharm. 2025;8(11):1136-1142. https://doi.org/10.1002/jac5.70123
• Jackson C, Williamson JC, Smith J. Filling the gaps: a review and update on beta-lactamase inhibitor combinations. Curr Infect Dis Rep. 2026;28:3. https://doi.org/10.1007/s11908-025-00874-y
• Kufel WD, Tudhal K, Hutson P, Mahapatra R, Rose WE, Volk C. Monthly dalbavancin dosing for suppressive therapy: a pharmacokinetic estimation analysis and case series. Antimicrob Agents Chemother. 2025;70(2):e0109225. https://doi.org/10.1128/aac.01092-25
• Nguyen CT, Brown AM, Lew AK, Pettit NN, Baccile R. Risk factors for coagulase-negative staphylococcal surgical site infections. Epidemiol Infect. 2025;153:e135. https://doi.org/10.1017/S0950268825100769
• Harris M, Bishop J, Olney WJ, Ali D, Nickols A, Parli SE. Darbepoetin alfa use in trauma/acute care surgery patients who abstain from blood products: a case series and discussion. Am J Health Syst Pharm. 2025;82(19):e796-e804. https://doi.org/10.1093/ajhp/zxaf099
• Nixon J, Parli SE, Bishop JM, et al. Assessment of therapeutic approaches: necrotizing soft tissue infections and the choice between vancomycin + clindamycin and linezolid. Surg Infect (Larchmt). 2025;26(7):467-473. https://doi.org/10.1089/sur.2024.281
• Vathy R, Cimino C, Ereshefsky B, Humphries R. Impact of institutional treatment guidance on the management and outcomes of Stenotrophomonas maltophilia and carbapenem-resistant Acinetobacter baumannii infections. Antimicrob Steward Healthc Epidemiol. 2025;5(1):e330. https://doi.org/10.1017/ash.2025.10244
• Patino K, Vathy R, Albrecht B, Suchindran S, Green SB. Combating resistant pathogens: exploring the efficacy of eravacycline utilization in multidrug-resistant infections. Microbiol Spectr. 2025;13(12):e01314-25. https://doi.org/10.1128/spectrum.01314-25
• Vazquez Deida AA, Kim C, Gouin KA, Zhang K, Mikosz CA, Neuhauser MM, Kabbani S. Assessment of high-volume antibiotic and opioid prescribing by Medicare Part D prescribers—United States, 2021. Public Health Rep. 2026;141(2):210-205. https://doi.org/10.1177/00333549251384449
• Jenkins TC, Vazquez Deida AA, Fish LE, Breyer MJ, Quinones A, Zwakenberg M, Hussain CK, Sabel AL, Shihadeh KC. The Take 5 Campaign: effects of an intervention to promote five-day durations of antibiotic therapy for common infections in urgent care. Open Forum Infect Dis. 2025;12(9):ofaf564. https://doi.org/10.1093/ofid/ofaf564
• Wagner JL, Oliver DR, Jones BM, Stover KR, Watts M, Kufel WD, McDowell L, McGee EU, Stevenson TL, Bland CM. Perceived knowledge and confidence of beta-lactam allergy management among pharmacy students on advanced pharmacy practice experiences. Pharmacy. 2025;13(5):135. https://doi.org/10.3390/pharmacy13050135

 Presentations

• Rachel Britt:
  • Out with the old, in with the new: time to update the management of Staphylococcus aureus infections. Should vancomycin be replaced in the MRSA guidelines? – con. Presented at: IDWeek; October 2025; Atlanta, GA.
  • A peer-to-peer on peer review: a panel with the experts. Presented at: American Society of Health-System Pharmacists Midyear Clinical Meeting; December 2025; Las Vegas, NV.
• Elizabeth Covington: Precepting in the age of AI: practical tools and ethical insights for pharmacy educators. Presented at: Auburn University Harrison College of Pharmacy, Continuing Education Webinar for Preceptors; September 2025; virtual.
• Wasim El Nekidy:
  • Drug dosing strategies in the context of extracorporeal therapies. Presented at: Cleveland Clinic Abu Dhabi Pharmacy Conference; November 2025; Abu Dhabi, UAE.
  • Death by 100 equations: eGFR for drug dosing. Presented at: Best of Society of Critical Care Medicine; November 2025; Abu Dhabi, UAE.
• Wes Kufel:
  • Putting “PEP” to the step: doxycycline post-exposure prophylaxis for Lyme disease prevention. Presented at: IDWeek 2025; October 2025; Atlanta, GA.
  • New epidemiologic realities—more bugs, more bites. Presented at: American College of Clinical Pharmacy Infectious Diseases Practice and Research Network Focus Session; ACCP Annual Meeting 2025; October 2025; Minneapolis, MN.
  • A peer-to-peer on peer review: a panel with the experts. Presented at: American Society of Health-System Pharmacists Midyear Clinical Meeting; December 2025; Las Vegas, NV.
• Cynthia Nguyen: Oral beta-lactams for severe gram-positive infections—ready for prime time? Presented at: IDWeek; October 2025; Atlanta, GA.
• Sara Parli: Navigating the ICU: essential pharmacy knowledge for surgeons. Presented at: Surgical Infection Society Webinar; September 2025; virtual.
• Nardine Salgado:
  • Use of ceftaroline and gentamicin for the management of methicillin-resistant Staphylococcus aureus bacteremia and prosthetic valve endocarditis. Presented at: American Society of Health-System Pharmacists Midyear Clinical Meeting and Exhibition; December 2025; Las Vegas, NV.
  • Clinical outcomes of patients with NDM-producing Enterobacterales bloodstream infections in a healthcare system in New York. Presented at: IDWeek; October 2025; Atlanta, GA.

Other Notable Achievements

• Entisar Almodyan:
  • BCIDP.
  • AAHIVP certification.
• Nardine Karam Salgado:
  • Chair of the Faculty Recruitment and Retention Committee for the Division of Pharmacy Practice at LIU Pharmacy.
  • ACCP Research and Scholarship Program Certificate (January 2026).

Nephrology PRN

 Awards

• Susan Lewis: Ronald and Deanna Tulley Award for Exemplary Research, Scholarship, or Creative Activity; University of Findlay.

 Publications

• Brown B, Schemmel J, Reinert JP, Baki G, Howard MS, Churchwell MD. Physical compatibility of ertapenem and meropenem in 0.45% normal saline and Plasma-Lyte A. Int J Pharm Compd. 2025;29(5):430-434.
• Ezema CG, Howard MS, Baki G, Churchwell MD, Reinert JP. The physical compatibility of orphenadrine citrate with 0.45% sodium chloride, lactated Ringer’s solution, and Plasma-Lyte A. Int J Pharm Compd. 2025;29(5):435-438.
• Grant KB, Churchwell MD, Baki G, Howard MS. In-vitro physical compatibility of intravenous doxycycline hyclate and acyclovir sodium. Medtigo J Pharmacol. 2025;2(4):e3061242. https://doi.org/10.63096/medtigo3061242
• Rhoney DH, Chen AMH, Thornby KA, Daugherty KK, Churchwell MD, et al. Assessing the current state of pharmacy education: a strengths-weaknesses-opportunities-threats analysis. Am J Pharm Educ. 2025;90(1):101898. https://doi.org/10.1016/j.ajpe.2025.101898
• Rhoney DH, Daugherty KK, Chen AMH, Churchwell M, et al. A unifying vision for pharmacy: defining professional identity through stakeholder perspectives. J Am Pharm Assoc (2003). 2025 Dec 23. [Epub ahead of print]. https://doi.org/10.1016/j.japh.2025.103013
• Rhoney DH, Daugherty KK, Chen AMH, Kleppinger EL, Churchwell MD, et al. The hidden architecture of inertia: stakeholder perspectives on the most pressing challenges in pharmacy education. Am J Pharm Educ. 2026;90(1):101899. https://doi.org/10.1016/j.ajpe.2025.101899
• Rhoney DH, Chen AMH, Thornby KA, Nelson NR, Daugherty KK, Churchwell MD, et al. Future-proofing pharmacy: a stakeholder-informed forecast of workforce and education needs. J Am Coll Clin Pharm. 2026;9(2):e70177. https://doi.org/10.1002/jac5.70177
• Rhoney DH, Daugherty KK, Chen AMH, Nelson NR, Thornby KA, Kleppinger EL, Churchwell MD, et al. From strength to struggle: stakeholder insights into the readiness of tomorrow’s pharmacists. Am J Pharm Educ. 2026;90(1):101900. https://doi.org/10.1016/j.ajpe.2025.101900
• Rowell H, Johnson RM, Baki G, Reinert JP, Churchwell MD, Howard MS. Physical compatibility of ceftazidime and ceftazidime/avibactam in 0.45% sodium chloride and Plasma-Lyte A. Int J Pharm Compd. 2025;29(6):453-462.
• Sowinski KM, Churchwell MD. Hemodialysis and peritoneal dialysis. In: Haines ST, Nolin TD, Ellingrod VL, et al, eds. DiPiro’s Pharmacotherapy: A Pathophysiologic Approach. 13th ed. McGraw Hill; 2026.
• Ghazi IM, Omar AF, El Nekidy WS, Harb G, Alrahmany D. Innate immune response to bacterial infections in hospitalized glucose-6-phosphate dehydrogenase-deficient patients; diagnostic value of white blood cell count. Clin Immunol. 2026;282:110613. https://doi.org/10.1016/j.clim.2025.110613
• Fravel MA, Ernst ME. Gout and hyperuricemia. In: Haines ST, Nolin TD, Ellingrod VL, et al, eds. DiPiro’s Pharmacotherapy: A Pathophysiologic Approach. 13th ed. McGraw Hill; 2026.
• Ernst ME, Fravel MA, Woods RL, et al. Prevalence of obesity, excess central adiposity, and cardiovascular risk among older adults. JACC Adv. 2025;4(10 pt 2):102150. https://doi.org/10.1016/j.jacadv.2025.102150
• Ernst ME, Sheets KM, Webb KL, Fravel MA, et al. Late-life, visit-to-visit blood pressure variability and its association with sex-specific long-term cognitive outcomes. J Hum Hypertens. 2025;39(12):831-840. https://doi.org/10.1038/s41371-025-01087-5
• Sheets KM, Webb KL, Woods RL, Orchard SG, Beilin L, Fravel MA, et al. Long-term blood pressure variability and physical performance in older adults. J Clin Hypertens (Greenwich). 2025;27(9):e70139. https://doi.org/10.1111/jch.70139
• Zhou Z, Fravel MA, Orchard SG, et al. Anti-hypertensive drug classes and risk of new-onset atrial fibrillation in healthy older adults: a post hoc analysis of ASPREE trial. Drugs Aging. 2025;42(12):1159-1167. https://doi.org/10.1007/s40266-025-01258-6
• Zhou Z, Polkinghorne KR, Tonkin AM, Woods R, Cai A, Zoungas S, Fravel MA, et al. Association between cardiovascular-kidney-metabolic syndrome and risks of 14 age-related health outcomes in primary prevention older population. GeroScience. 2026 Jan 12. [Epub ahead of print]. https://doi.org/10.1007/s11357-025-02058-x
• Hudson JQ, Chang AR, Condon Martinez AJ, Maxson R, Meaney CJ, St. Peter WL. Optimizing comprehensive medication management in CKD: an opportunity to integrate pharmacists in the kidney care team. Am J Kidney Dis. 2026;87(3):433-442. https://doi.org/10.1053/j.ajkd.2025.09.024
• Khan RW, Gipson G. Disorders of potassium and magnesium homeostasis. In: Haines ST, Nolin TD, Ellingrod VL, et al, eds. Pharmacotherapy: A Pathophysiologic Approach. 13th ed. McGraw Hill; 2026.
• Khan RW, Zacholski EH. Active learning strategies. In: Koehler JM, Borchert JS, Slain D, et al, eds. Schwinghammer’s Pharmacotherapy Casebook: A Patient-Focused Approach. 13th ed. McGraw Hill; 2026.
• Bauman A, Caiazza OG, Wan N, Payer S, Pauly OG, Shoemaker S, Lewis SJ. Evaluation of high-dose post-dialytic versus daily beta-lactam dosing in hemodialysis patients using Monte Carlo simulation. Int J Clin Pharm. 2025 Nov 26. [Epub ahead of print]. https://doi.org/10.1007/s11096-025-02044-5
• Oestreich JH, Hendershot R, Lewis SJ, Guy JW. Pathfinder: a modified collaborative game for learning and team building. Innov Pharm. 2025;16(3). https://doi.org/10.24926/iip.v16i3.6187
• Tripp EK, Lewis SJ, Richardson JL. Prevalence and predictors of diabetes distress in hospitalized patients: a pharmacist-led intervention. J Am Coll Clin Pharm. 2025;8(11):1153-1160. https://doi.org/10.1002/jac5.70121
• Martinez A. Kidney pharmacy services model associated with better outcomes for patients on dialysis. Nephrology News & Issues. https://www.healio.com/news/nephrology/20251106/kidney-pharmacy-services-model-associated-with-better-outcomes-for-patients-on-dialysis
• Nemecek BD, St. Peter WL, Hong LT, Anderson ER, El Nekidy WS. Current practices in estimating kidney function: insights from a cross-sectional survey. J Am Coll Clin Pharm. 2025;8(11):1136-1142. https://doi.org/10.1002/jac5.70123
• Rungkitwattanakul D, St. Peter W, El Nekidy WS, Hudson JQ, Kane-Gill SL, Nemecek BD, Webb AJ, Bzowyckyj AS, Wallace JL. Reply to comment on “Adopting race-free estimated glomerular filtration rate for unifying medication-related decision-making: an opinion of the Nephrology Practice and Research Network of the American College of Clinical Pharmacy.” J Am Coll Clin Pharm. 2026;9(2):e70180. https://doi.org/10.1002/jac5.70180
• Wallace JL, Rungkitwattanakul D, Khan RW, Anderson L, Anderson ER, El Nekidy WS, Nemecek BD, Meaney CJ, Prasad-Reddy L, Salama L, Hudson JQ, Kane-Gill SL, Barreto EF, Bzowyckyj AS, St. Peter W. Adopting race-free estimated glomerular filtration rate for unifying medication-related decision-making: an opinion of the Nephrology Practice and Research Network of the American College of Clinical Pharmacy. J Am Coll Clin Pharm. 2026;9(2):e70153. https://doi.org/10.1002/jac5.70153
• Schumacher C. Cardiovascular-kidney-metabolic (CKM) syndrome. In: Sanoski CA, Witt DM, eds. Pharmacotherapy Self-Assessment Program, 2026 Book 1. Endocrinology and Nephrology. American College of Clinical Pharmacy; 2026:1-18.

Presentations

• Mariann Churchwell:
  • AACP pearls. Presented at: University of Toledo College of Pharmacy and Pharmaceutical Sciences Faculty Development Series; September 2025; Toledo, OH.
  • Bridging the gap: applying competency-based pharmacy education to resident growth. Presented at: Ohio Society of Health-System Pharmacists Annual Meeting; October 2025; Columbus, OH.
  • Bridging the gap: applying competency-based pharmacy education to resident growth. Presented at: University of Toledo College of Pharmacy and Pharmaceutical Sciences Preceptor Development; December 2025; Toledo, OH.
• Amanda Condon Martinez:
  • Renal pharmacy services reduce mortality and hospital burden in hemodialysis. Presented at: American Society of Nephrology Kidney Week; November 2025; Houston, TX.
  • Optimizing medication safety for patients with end-stage kidney disease through point-of-verification clinical evaluations. Presented at: American Society of Nephrology Kidney Week; November 2025; Houston, TX.
• Wasim El Nekidy: Drug dosing strategies in the context of extracorporeal therapies. Presented at: Cleveland Clinic Abu Dhabi Pharmacy Conference; November 2025; Abu Dhabi, UAE.
• Michelle Fravel:
  • Systolic blood pressure discordance in kidney function estimation and associated drug dosing recommendations in older adults. Poster presented at: 2025 ACCP Annual Meeting; October 2025; Minneapolis, MN.
  • Unmasking liver risks: OTC supplements trigger transient hepatotoxicity in ADPKD patients on tolvaptan. Poster presented at: 2025 ACCP Annual Meeting; October 2025; Minneapolis, MN.
  • Systolic blood pressure time-in-target range and long-term kidney outcomes in older adults. Poster presented at: 2025 ACCP Annual Meeting; October 2025; Minneapolis, MN.
  • Sleep disturbances and the utilization of medication sleep aids in older adults. Poster presented at: 2025 ACCP Annual Meeting; October 2025; Minneapolis, MN.
  • Long-term systolic time in target range and risk of cardiovascular disease events in community-dwelling older adults. Poster presented at: American Heart Association: Hypertension Scientific Sessions 2025; September 4-7, 2025; Baltimore, MD.
• Susan J. Lewis: Evaluation of high-dose post-dialytic ceftazidime/avibactam in kidney failure patients with hemodialysis using Monte Carlo simulation. Poster presented at: 2025 ACCP Annual Meeting, Minneapolis, MN; October 18-21, 2025; Minneapolis, MN.
• Christie Schumacher: The next step in medication reconciliation: integrating comprehensive medication management strategies at care transitions: creating a role for comprehensive medication management in transitions of care. Presented at: 2025 ACCP Annual Meeting; October 2025; Minneapolis, MN.

New ACCP Fellows

• Rachel Khan

Other Notable Achievements

• Christie Schumacher: Appointed to the American Diabetes Association (ADA) Professional Practice Committee, which is responsible for writing and updating the ADA Standards of Care for 2027 and 2028.

Pain and Palliative Care PRN

Publications

• Shiplett L, Shah NK, Field N, Gruver S, Hu A. Clinical pharmacist-led low-dose buprenorphine initiations (microinductions): a case series. J Pain Palliat Care Pharmacother. 2026 Feb 17. [Epub ahead of print]. https://doi.org/10.1080/15360288.2026.2624497

Presentations

• Lisa Luciani:
  • An exploration of painful neuropathy in the context of long COVID: mechanisms, manifestations, and management. Presented at: PainWEEK 2025 Annual Conference; September 2025; Las Vegas, NV.
  • Effect of long-term opioid therapy on sexual dysfunction in pain patients. Presented at: PainWEEK 2025 Annual Conference; September 2025; Las Vegas, NV.

Pediatrics PRN

Promotions/Appointments

• Elizabeth J. Beckman:
  • Data Safety Monitoring Board, Optimizing Pain Treatment in Children on Mechanical Ventilation (OPTICOM) [NIH/NICHD Funded].
  • Panelist, Board of Pharmacy Specialties BCCCP 2026 Job Analysis.

Awards

• Pete Johnson: 2026 Pediatric Pharmacy Association Richard Helms Award, Pediatric Pharmacy Association.
• Michael J. Raschka: 2025 Young Alumnus of the Year, University of Wisconsin-Madison School of Pharmacy.
• Karen Williams: Outstanding Original Paper Award, Pediatric Pharmacy Association. “Improving naloxone co-prescribing utilizing best practice advisory alert for pediatric patients: a pilot study.”

Publications

• Almalki A, Alajmi NM, Al Lohaibi R. Meropenem-induced acute liver injury in a pediatric patient with severe combined immunodeficiency: a case report. Saudi J Clin Pharm. 2025;4(4):142-146. https://doi.org/10.4103/sjcp.sjcp_21_25
• Beckman EJ, McCormick A, Vidrine RM. Incidence of QTc prolongation with dexmedetomidine use in hospitalized pediatric patients. J Am Coll Clin Pharm. 2025;8(12):1436. https://doi.org/10.1002/jac5.70148
• Wolff J, Cober MP, Huff KA. Essential fatty acid deficiency in parenteral nutrition: historical perspective and modern solutions, a narrative review. Nutr Clin Pract. 2025;40(2):350-367. https://doi.org/10.1002/ncp.11278
• Foote D, Le M, Johnson P, Miller J, Behere S, Stephens KS. Ivabradine use for arrhythmias in children. Ann Pharmacother. 2025 Dec 10. [Epub ahead of print]. https://doi.org/10.1177/10600280251373074
• Kiskaddon AL, Rech M, Amankwah E, Dallas L, Stang C, Robinson J, Sinclair-Pingel J, Smith C, Johnson P, Ordons K, Beckman E, et al. Antithrombotic medication interventions by pediatric pharmacists in critically ill children. Res Pract Thromb Haemost. 2025;9(suppl 2):102930. https://doi.org/10.1016/j.rpth.2025.102930
• McLarty T, Giglione A, Miller JL, Lewis TV, Johnson PN. Systemic review of pharmacological treatments for hypochloremic metabolic alkalosis in critically ill children. J Pediatr Pharmacol Ther. 2026;31(1):4-17. https://doi.org/10.5863/JPPT-25-00038
• Musburger BG, Gonzalez Echeandia M, Suskind EL, Suskind DL, Zheng HB, Mark D. Current and emerging therapies for eosinophilic esophagitis (EoE): a comprehensive review. Pharmaceutics. 2025;17(6):753. https://doi.org/10.3390/pharmaceutics17060753
• Pan I, Lin C, Palestine AG, Edwards Mayhew RG, Jung JL. Use of tacrolimus for the treatment of pediatric noninfectious uveitis. Ophthalmol Ther. 2025;15(1):457-465. https://doi.org/10.1007/s40123-025-01275-z
• Lockwood B, Wu J, Pehl H, Murray L, Mathew S, Graeff C, Townzen D, Babbrah P, Kosar D, Rochon J, Spiro S, Parrish R. EHR certification criteria guidance document for post acute care pharmacy. December 12, 2025. https://pharmacyhit.org/wp-content/uploads/WG4-EHR-Certification-Criteria-Guidance-Document-for-Pharmacy-Final-Version-9.pdf
• Tabulov CE. Creation and implementation of a transplant medication patient education game for adolescents by a pediatric pharmacist and pharmacy students. Am J Health Syst Pharm. 2026;83(4):176-182. https://doi.org/10.1093/ajhp/zxaf187

Presentations

• Elizabeth J. Beckman. Propofol time-out: washing out to wake up the kids. Presented at: Live webinar for Pediatrics PRN. American College of Clinical Pharmacy; January 10, 2026; virtual.
• Michael J. Raschka:
  • Pharmacology and kids: the drugs we give, the drugs they take. Presented at: Live webinar for Heartland EMS for Children Coalition; December 12, 2025; virtual.
  • Keynote Speaker. Presented at: University of Wisconsin – School of Pharmacy White Coat Ceremony; September 9, 2025; Madison, WI.

Other Notable Achievements

• Mary Petrea Cober: Fellow, NEOMED Masters Teacher Guild.

Perioperative Care PRN

Promotions

• Michelle Dansby: Pharmacy Operations Manager, Self Regional Healthcare, Greenwood, SC.
• Rachel Wolfe: Voluntary Clinical Assistant Professor, Department of Anesthesiology, Washington University School of Medicine, St Louis, MO.
• Tonya Wright: Clinical Pharmacy Specialist for Surgical Services, Riverside Regional Medical Center, Newport News, VA.

Awards

• Sally Tice: Apple Pin Award, Geisinger Academy of Educators.

Publications

• Birrer KL (as part of the OPTIM Investigator Team). Optimizing pharmacist team‐integration for ICU patient management (OPTIM): recruitment and retention strategies to mobilize a professional community. J Am Coll Clin Pharm. 2026;9(2):e70154. https://doi.org/10.1002/jac5.70154
• Judickas SJ, Hyland SJ. Preventing venous thromboembolism after foot and ankle surgery: a rapid review. Podiatry Today. 2025;38(8). Published August 1, 2025.
• Linn DD, Renew JR. Postoperative benefits of sugammadex: a narrative review. Am J Health Syst Pharm. 2026;83(5):e183-e191. https://doi.org/10.1093/ajhp/zxaf213
• Gamcsik S, McKenzie JJ, Kissel-Smith H, Wills B. Converting oral to intravenous methadone in a hospitalized patient with opioid use disorder: a case report. Am J Ther. 2025 Nov 7. [Epub ahead of print]. https://doi.org/10.1097/MJT.0000000000002001
• Gibson CM, Escaño AK, McKenzie JJ, Wijesinghe DS, Donohoe KL. Enhancing student knowledge and confidence through two sequential total parenteral nutrition active learning approaches. Curr Pharm Teach Learn. 2025;17(9):102396. https://doi.org/10.1016/j.cptl.2025.102396
• Harris M, Bishop J, Olney WJ, Ali D, Nickols A, Parli SE. Darbepoetin alfa use in trauma and acute care surgery patients who abstain from blood products: a case series and discussion. Am J Health Syst Pharm. 2025;82(19):e796-e804. https://doi.org/10.1093/ajhp/zxaf099
• Nixon J, Parli SE, Bishop JM, et al. Assessment of therapeutic approaches: necrotizing soft tissue infections and the choice between vancomycin + clindamycin and linezolid. Surg Infect (Larchmt). 2025;26(7):467-473. https://doi.org/10.1089/sur.2024.281
• Wolfe RC. Perioperative hyperkalemia and post-treatment hypoglycemia. J Perianesth Nurs. 2025;40(4):1069-1071. https://doi.org/10.1016/j.jopan.2025.05.024
• Battles E, Wolfe RC. Methadone use in the postanesthesia care unit setting. J Perianesth Nurs. 2025;40(6):1639-1640. https://doi.org/10.1016/j.jopan.2025.08.016

Presentations

• Sara Parli: Navigating the ICU: essential pharmacy knowledge for surgeons. Presented at: Surgical Infection Society Webinar; September 2025; virtual.

New ACCP Fellows

• Karra Birrer

Other Notable Achievements

• Birrer KL. Acute ischemic stroke and neuroendovascular procedures. In: Smith Z, Zimmerman L, eds. Critical Care Self-Assessment Program, 2026. American College of Clinical Pharmacy, 2026:23-57.

Pharmaceutical Industry PRN

Promotions

• Rick Barbarash: National Field Director, Neurology Medical Science Liaisons, Ultragenyx Pharmaceutical, Inc.

Awards

• Sarah Nisly:
  • 2026 Alliance Award for Outstanding Outcomes in CE (industry sponsored) through the Alliance for Continuing Education in the Health Professions.
  • 2026 Alliance Distinguished Member Alliance for Continuing Education in the Health Professions.

Publications

• Irwin AN, Spinler SA, Baye JF, Bulloch MN, Byerley SD, Evans E, Florczykowski B, Fritz MK, et al. Clinical pharmacists and industry: guidelines for professional interactions. J Am Coll Clin Pharm. 2026;9(3):e70190. https://doi.org/10.1002/jac5.70190
• Brown SA, Cooley J, Cat T, Frederick KD, Larson S, Nisly SA. Using growth mindset to navigate challenges in pharmacy education. Am J Pharm Educ. 2026;90(2):101917. https://doi.org/10.1016/j.ajpe.2025.101917

Presentations

• Brittany Florczykowski:
  • Women in cardiology career panel. Presented at: Pittsburgh Heart Summit; September 18, 2025; Pittsburgh, PA.
  • Patient case panel: MINOCA. Presented at: Pittsburgh Heart Summit; September 18, 2025; Pittsburgh, PA.
• Mark Shaefer: Finding and acquiring non-government source grants. Presented at: 2025 ACCP Annual Meeting; October 18, 2025; Minneapolis, MN.
• Lauren Williams: Industry: friend or foe? Presented at: 2025 ACCP Annual Meeting: October 20, 2025; Minneapolis, MN.

Other Notable Achievements

• Rachael G. Pirrami: Started a fellowship at Takeda & Massachusetts College of Pharmacy and Health Sciences (MCPHS) as a Global Clinical Supply Chain Fellow and started a part-time job as a behavioral health staff pharmacist at Arbour Hospital.
• Mark Shaefer: Appointed to the ACCP Foundation Board of Directors for a 3-year term.

Pharmacokinetics/Pharmacodynamics/Pharmacogenomics PRN

Promotions

• Kelly E. Caudle: Associate Member, St Jude Children’s Research Hospital.

Awards

• Christine Kroger: Distinguished Young Pharmacist Award, Minnesota Pharmacists Association.
• Amy Pasternak: ACCP Best Poster Finalist, ACCP.
• James M. Stevenson: Feroli Award for Excellence in Medication Safety, Johns Hopkins University Armstrong Institute for Patient Safety.

Publications

• Brady H, Weaver M, Baye J, Massmann A. Evaluation of the impact of CYP2D6 testing on outcomes in patients taking opioids. J Am Pharm Assoc (2003). 2025;65(6):102905. https://doi.org/10.1016/j.japh.2025.102905
• Caudle KE, Whirl-Carrillo M, Relling MV, Hoffman JM, Donnelly RS, Haidar CE, Bourque MS, et al. Advancing clinical pharmacogenomics worldwide through the Clinical Pharmacogenetics Implementation Consortium (CPIC). Clin Pharmacol Ther. 2025;118(6):1512-1522. https://doi.org/10.1002/cpt.70005
• Klein CJ, Gong L, Caudle KE, Naik H, Empey PE, Hoffman JM, Scherer S, Iwuchukwu OF, Gregornik D, et al. Toward an integrated resource for pharmacogenomics (PGx): survey findings from the genomic medicine communities. Genet Med. 2025;27(10):101529. https://doi.org/10.1016/j.gim.2025.101529
• Maillard M, Schwab M, Whirl-Carrillo M, Moyer AM, Suarez-Kurtz G, Pui CH, Stein CM, Klein TE, Spahn C, Kwon S, Hartono JL, de Boer NK, Ahmad T, Antillon-Klussmann FG, Caudle KE, et al. Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for thiopurine dosing based on TPMT and NUDT15 genotypes: 2025 update. Clin Pharmacol Ther. 2026 Jan 31. [Epub ahead of print]. https://doi.org/10.1002/cpt.70209
• Fieg E, Kerman B, Frear S, Donnelly RS. Power of the pedigree: specialty referrals from a pharmacogenomics clinic. J Genet Couns. 2025;34(6):e70131. https://doi.org/10.1002/jgc4.70131
• Tibben BM, Gaedigk A, Gong L, Sangkuhl K, Whirl-Carrillo M, Relling MV, Donnelly RS, Klein TE, Caudle KE. The Clinical Pharmacogenetics Implementation Consortium’s consensus-based framework for assigning allele function. Am J Hum Genet. 2025;112(12):2842-2859. https://doi.org/10.1016/j.ajhg.2025.10.004
• Eadon MT, Hein DW, Andersen MA, Chapman AB, Cooper-DeHoff RM, Desta Z, Duarte JD, Elchynski AL, Gaedigk A, Karol SE, Limdi NA, Lteif C, Sosinski L, Zubiaur P, Whirl-Carrillo M, Klein TE, Caudle KE, Donnelly RS, et al. Clinical Pharmacogenetics Implementation Consortium guideline for NAT2 genotype and hydralazine therapy. Clin Pharmacol Ther. 2025;118(6):1430-1436. https://doi.org/10.1002/cpt.70071
• Denton J, Watkins SA, Shirazi FM, Walter FG, Karnes JH, et al. Characterization of anemia following rattlesnake envenomation in Arizona: a retrospective observational study. Clin Toxicol (Phila). 2026 Feb 4. [Epub ahead of print]. https://doi.org/10.1080/15563650.2026.2616423
• Ghisays V, Khajouei E, Piras IS, Malek-Ahmadi MH, Protas HD, Goradia DD, Chen Y, Naymik M, Saner D, Veatch OJ, Mansel CO, Su Y, Huentelman MJ, Karnes JH, et al. Impact of APOE4-related dementia risk in underrepresented groups from the All of Us research program. Alzheimers Dement. 2025;21(6):e70245. https://doi.org/10.1002/alz.70245
• Gronich N, Naama GZ, Herren R, Kelly L, Cohen Z, Zhou H, Chen YC, Shah K, Robinson-Catalan TA, Frisby G, Karnes JH, et al. Pharmacomicrobiomics. Clin Pharmacol Ther. 2025;118(6):1366-1377. https://doi.org/10.1002/cpt.70066
• Tafazoli A, Hemmati M, Rafigh M, Alimardani M, Khaghani F, Korostyński M, Karnes JH. Leveraging long-read sequencing technologies for pharmacogenomic testing: applications, analytical strategies, challenges, and future perspectives. Front Genet. 2025;16:1435416. https://doi.org/10.3389/fgene.2025.1435416
• Massmann A, Baye JF, Weaver M. Developing a statistical modeling-based machine learning approach for capturing drug dosing using a proton pump inhibitor case. Pharmacotherapy. 2026;46(2):e70083. https://doi.org/10.1002/phar.70083
• Massmann A, Petry NJ, Weaver M, Brady H, Lupu RA. Analyzing the impact of pharmacogenomics-guided nonsteroidal anti-inflammatory drug alerts in clinical practice. JAMIA Open. 2025;8(5):ooaf112. https://doi.org/10.1093/jamiaopen/ooaf112
• Mohamed ME, Saqr A, Onyeaghala G, Remmel RP, Staley C, Dorr CR, Teigen L, Guan W, Vo D, El-Rifai R, Oetting WS, Matas AJ, Israni AK, Jacobson PA. A mycophenolate pharmacokinetic study with new insights into enterohepatic recirculation in kidney transplant recipients. Clin Pharmacokinet. 2026;65(3):479-495. https://doi.org/10.1007/s40262-025-01611-3
• Nugent KI, Huang L, Nazzal M, Pasternak AL, Hertz DL. Association of genetic variation with irinotecan infusion reactions and severe toxicity. Pharmacogenet Genomics. 2025;35(8):226-231. https://doi.org/10.1097/FPC.0000000000000574
• Zhao K, Lam V, Eschenauer G, Vanderwerff B, Zöllner S, Hertz DL, Aitken SL, Pasternak AL. The role of uridine diphosphate glucuronosyltransferase 1A4 polymorphisms on posaconazole exposure. Pharmacogenet Genomics. 2026 Feb 2. [Epub ahead of print]. https://doi.org/10.1097/FPC.0000000000000594
• Rackow AR, Snyder I, Stevenson JM, Knezevic CE, Marzinke MA. Evaluation of the availability of clinical pharmacogenomics within the United States and utilization within an academic healthcare system. J Lab Precis Med. 2025 Oct 10. https://doi.org/10.21037/jlpm-25-25
• Rattsev I, Stevenson JM, Taylor CO. A framework to quantify disparities in pharmacogenomic treatment concordance and drug response outcomes. Clin Transl Sci. 2026;19(2):e70501. https://doi.org/10.1111/cts.70501
• Sulaiman A, Gilbert C, Stevenson JM, Swartz K, Marzinke MA. Provider perceptions on the clinical utility of pharmacogenomics testing: views of psychiatry physicians from an academic center. Pharmacogenomics. 2025;26(17-18):673-681. https://doi.org/10.1080/14622416.2026.2624534
• Khajouei E, Ghisays V, Piras IS, Martinez KL, Naymik M, Ngo P, Tran TC, Denny JC, Wheeler TJ, Huentelman MJ, Reiman EM, Karnes JH. Phenome-wide association of APOE alleles in the All of Us research program. EBioMedicine. 2025;117:105768. https://doi.org/10.1016/j.ebiom.2025.105768

Other Notable Achievements

• Kelly Caudle: Web of Science Highly Cited Researcher 2025 (highly cited papers that ranked in the top 1% in 2025 in the field of Pharmacology and Toxicology).

Pulmonary PRN

Awards

• Hanna Phan: 2025 Cystic Fibrosis Foundation Mary M. Kontos Care Champion Award, awarded at 2025 North American Cystic Fibrosis Conference.

Publications

• Boylan PM, Skrepnek G, Neely S, et al. Montelukast deprescribing and neuropsychiatric events in older adults: a cross-sectional descriptive report. Geriatr Pharmacol. 2026;3(1):Article 2621471. https://doi.org/10.1080/2994399X.2026.2621471
• North A, Skrepnek G, Atkins RM, Skaggs J, Wu H, Boylan PM. Comparing ASHP and PQA frameworks for identifying medication therapy problems in older adults with COPD discharged to home health care: a cross-sectional study. Sr Care Pharm. 2026;41(1):34-42. https://doi.org/10.4140/TCP.n.2026.34
• Oldham M, Benavides S, Boylan PM. Navigating measles treatment in 2025: a review on vaccines, medications, and supplements. Pediatr Allergy Immunol Pulmonol. 2025;38(4):113-118. https://doi.org/10.1177/2151321X251397927
• Young J, Novak K, Boylan P. What are alternatives to oral phenylephrine in children? Pediatr Allergy Immunol Pulmonol. 2025;38(3):83-37. https://doi.org/10.1089/ped.2025.0031
• Bender BG, Begay E, Crooks J, Gerald JK, Hudson B, King DK, Kobernick A, Liu AH, Lowe AA, Morgan W, Nez P, Phan H, et al. Outcomes of the Navajo Community Asthma Program during the COVID-19 pandemic. J Allergy Clin Immunol Glob. 2025;5(1):100593. https://doi.org/10.1016/j.jacig.2025.100593
• Kadouh NK, Nasr SZ, Filbrun A, Phan H. A tale of two infants: off-label use of elexacaftor/tezacaftor/ivacaftor in early cystic fibrosis treatment. Pediatr Pulmonol. 2026;61(1):e71444. https://doi.org/10.1002/ppul.71444
• Van Citters AD, Carey K, Ren CL, Phan H, et al. Financial and healthcare tradeoffs associated with cystic fibrosis care in the United States: a cross-sectional study. J Cyst Fibros. 2025 Dec 29. [Epub ahead of print]. https://doi.org/10.1016/j.jcf.2025.12.021

Presentations

• Paul Boylan: From echinacea to evidence: herbals and supplements for cold and flu season. Presented at: The Walter P. Scheffe Continuing Pharmaceutical Education Series; November 2025; Oklahoma City, OK.

New ACCP Fellows

• Melissa Lipari

Other Notable Achievements

• Megan Fleischman: 2025 Graduate of ACCP Leadership Development Program.
• Jeffrey Gonzales: 2025 Graduate of ACCP Leadership Development Program.
• Melissa Lipari: 2025 Graduate of ACCP Leadership Development Program.

Transplant PRN

 Awards

• Kellie Goodlet: 2025 American College of Clinical Pharmacy (ACCP) Annual Meeting Best Poster Award.

 Publications

• Belfield K, Walter K, Marvin J, Bonner R, Carlson R, Szempruch KR. Use of cystatin C as a marker for estimated glomerular filtration rate in non-kidney recipients. Transplant Rev. 2025;40(1):100970. https://doi.org/10.1016/j.trre.2025.100970
• Hudson JQ, Chang AR, Condon Martinez AJ, Maxson R, Meaney CJ, St. Peter WL. Optimizing comprehensive medication management in CKD: an opportunity to integrate pharmacists in the kidney care team. Am J Kidney Dis. 2025;87(3):433-442. https://doi.org/10.1053/j.ajkd.2025.09.024
• Goodlet KJ, Nailor MD, Hodges A, Pham C, Tokman S. Inhaled tobramycin dose and systemic absorption in lung transplant recipients without cystic fibrosis. Transpl Infect Dis. 2025 Dec 26. [Epub ahead of print]. https://doi.org/10.1111/tid.70158
• Ahmad S, Bay C, Nailor M, Pham C, Bremner R, Saeed IA, Goodlet KJ, et al. Kaposi sarcoma in lung transplant recipients with public health service increased-risk donors: a retrospective cohort study and review of the literature. JHLT Open. 2026;11:100468. https://doi.org/10.1016/j.jhlto.2025.100468
• Pham C, Le K, Bay C, Garcia R, Nailor MD, Goodlet KJ, et al. Accuracy of CYP3A5 pharmacogenomics recommended dosing of tacrolimus with concomitant azole antifungals early post-lung transplant. Clin Transplant. 2025;39(10):e70345. https://doi.org/10.1111/ctr.70345
• Unwin N, Goodlet KJ, Padiyar J, Tokman S, Pham C, Garcia R. Optimizing heparin induced thrombocytopenia risk assessment: investigating the role of the 4Ts score after lung transplantation. Clin Transplant. 2025;39(11):e70396. https://doi.org/10.1111/ctr.70396
• Henricksen E, Walter K, Lichvar A. Current state of drug therapies for antibody-mediated rejection after heart transplantation. Can J Cardiol. 2026;42(2):346-355. https://doi.org/10.1016/j.cjca.2025.10.005
• Khalil K, Kataria A, Phillippupillai R, Brokhof M, Kenyon N, Kumar V, Stern J, Harris M. The impact of specialty pharmacy mandates on the solid organ transplant population. Clin Transplant. 2025;39(9):e70288. https://doi.org/10.1111/ctr.70288
• Martinez A. Kidney pharmacy services model associated with better outcomes for patients on dialysis. Nephrology News & Issues. https://www.healio.com/news/nephrology/20251106/kidney-pharmacy-services-model-associated-with-better-outcomes-for-patients-on-dialysis
• Allen RB, Stevenson E, Goley AL, Alexander B, Ma J, Raiger TB, Chandran MM, Szempruch KR. Should early hyperglycemia be considered a risk factor for post-transplant diabetes mellitus? Findings from a retrospective cohort study in kidney transplant recipients without diabetes mellitus prior to transplant. Transplantology. 2025;6(4):30. https://doi.org/10.3390/transplantology6040030
• Byrne M, Waldron KM, McKinzie BP, Szempruch KR, et al. Development of a standard process to identify, implement, and validate pharmacist-impacted clinical outcome measures in the acute care setting. Part II. Am J Health Syst Pharm. 2025 Jul 21. [Epub ahead of print]. https://doi.org/10.1093/ajhp/zxaf185
• Madduri S, Szempruch KR, Chen M, Desai CS. Perioperative pain management for complex pancreatic resections for patients with chronic pancreatitis. Pancreas. 2025;54(9):e743-e747. https://doi.org/10.1097/MPA.0000000000002513
• Tinoco E, Lineberry E, McKinzie BP, Szempruch KR, et al. Development of a standard process to identify, implement, and validate pharmacist-impacted clinical outcome measures in the acute care setting. Part I. Am J Health Syst Pharm. 2025 Jul 21. [Epub ahead of print]. https://doi.org/10.1093/ajhp/zxaf186
• Walter K, Chen A, Hagopian J, et al. Belatacept-based immunosuppression in lung transplant recipients with calcineurin inhibitor renal toxicities. Transplantology. 2025;6(4):31. https://doi.org/10.3390/transplantology6040031

 Presentations

• Amanda Condon Martinez:
  • Renal pharmacy services reduce mortality and hospital burden in hemodialysis. Presented at: American Society of Nephrology Kidney Week; November 2025; Houston, TX.
  • Optimizing medication safety for patients with end-stage kidney disease through point-of-verification clinical evaluations. Presented at: American Society of Nephrology Kidney Week; November 2025; Houston, TX.
• Emily Garcia, Nicole Alvey, Marissa Brokhof, Elizabeth Cohen, Olivia Huber, and Kristen Szempruch: Expanding reach and engagement: the Transplant Practice and Research Network social media approach. Poster presented at: 2025 ACCP Annual Meeting; October 2025; Minneapolis, MN.
• Kellie Goodlet:
  • Clinical outcomes of lung transplant recipients with carbapenem-resistant Enterobacterales infections. Poster presented at: CHEST; October 2025; Chicago, IL.
  • Impact of Candida respiratory colonization on pleural space infection risk after lung transplantation. Poster presented at: 2025 ACCP Annual Meeting 2025; October 2025; Minneapolis, MN.
• Kristen Szempruch:
  • Case report of obinutuzumab use for antibody-mediated rejection in kidney transplantation. Poster presented at: 2025 ACCP Annual Meeting; October 2025; Minneapolis, MN.
  • Case series on management of BK polyomavirus with belatacept-based immunosuppression regimen in kidney transplant recipients. Poster presented at: 2025 ACCP Annual Meeting; October 2025; Minneapolis, MN.
  • The application of cystatin C in adult liver transplant recipients. Poster presented at: 2025 ACCP Annual Meeting; October 2025; Minneapolis, MN.

Women’s Health PRN

 Publications

• Hunter M, Coig R, Risler L, Patton KK, Narla RR, Greene DN, Burke AK, Micks E, Hebert MF, Cirrincione LR. Effect of testosterone therapy on cytochrome P450 3A and P-glycoprotein activities using midazolam and digoxin as probe substrates among transgender adults. Pharmacotherapy. 2026;46(2):e70093. https://doi.org/10.1002/phar.70093
• Poage AC, Rowe JM, Dameron MBA, Bavuso AM, Smith AJ. Comparison of subcutaneous versus intramuscular estradiol administration for feminizing gender-affirming hormone therapy. Pharmacy (Basel). 2026;23;14(1):13. https://doi.org/10.3390/pharmacy14010013
• Walley AH, Dupuis LN, Woodahl EL, Killam SR. Ibrexafungerp: mechanism of action, clinical, and translational science. J Clin Transl Sci. 2025;18(9):e70362. https://doi.org/10.1111/cts.70362

Presentations

• Adelynne Walley: Exploring pharmacy professionals’ knowledge, perceptions, and practices related to climate change adaptation: a focus on wildfire smoke and extreme heat. Poster presented at: International Pharmaceutical Federation (FIP) 2025 World Congress; August-September 2025; Copenhagen, Denmark.